skip to content »

Neurology

Houston, Texas

The Cullen Building at Baylor College of Medicine.
Department of Neurology
not shown on screen

Poster and Platform Presentations by BCM Neurology

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

Time Line

Expand All

2014

Collapse All | Expand All

 

    American Academy of Neurology (AAN)
    66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)

    • New risk score improves vasospasm prediction following subarachnoid hemorrhage using markers of vascular compliance.

      Anand A, Hussein H, Ezzeddine M, Kass J, Suarez J

    • Optical coherence tomography visualization of optic nerve head structure detects acute changes in the intracranial pressure.

      Anand A, Pass A, Calvillo E, Tang R, Cajavilca C, Urfy M, et al.

    • Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Treatment patterns and subject disposition.

      Charles P, Jankovic J, Comella C, Stacy M, Schwartz M, Manack A, et al.

    • Graph theory based functional connectivity in lateralized temporal lobe epilepsy.

      Chiang S, Stern J, Engel J, Levin H, Haneef Z

    • Cardiac valve strands in ischemic stroke: Strand effects and outcomes of medical or surgical intervention.

      Chu J, Fabian R

    • Clinimetric testing of the modules for the Comprehensive Cervical Dystonia Rating Scale (CCDRS).

      Comella C, Perlmutter J, Jinnah H, Adler C, Barbano R, Factor S, et al.

    • Multiple autoimmune antibody limbic encephalitis: A case in a pregnant woman.

      Goyal M, Gildersleeve K, Tomko S, Kass J

    • Treatment outcomes in Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE).

      Jankovic J, Adler C, Charles P, Comella C, Stacy M, Schwartz M, et al.

    • Use of interleaving in deep brain stimulator programming in patients with movement disorders.

      Jimenez-Shahed J, Waln O

    • Epidemiological pilot analysis of epilepsy patients in a community clinic aims to inform effective care.

      Karas L, Goldsmith C, Ruppelt SC, Goldman A

    • How long is long enough? The utility of prolonged inpatient video EEG monitoring.

      Moseley BD, Dewar S, Haneef Z, Stern J

    • Thrombolytic outcomes for acute ischemic stroke in patients with primary brain tumors in the United States.

      Murthy S, Moradiya Y, Shah S, Shastri A, Bershad E, Suarez J

    • Clinical outcomes of aneurysmal subarachnoid hemorrhage with cocaine use in the United States.

      Murthy S, Shah S, Moradiya Y, Shastri A, Smirnakis S

    • Myelitis following intrathecal chemotherapy in acute lymphoblastic leukemia: A case report.

      Parker A, Yassin A, Woodman K

    • Alleviating maneuvers (sensory tricks) in cervical dystonia.

      Patel N, Hanfelt J, Marsh L, Jankovic J

    • Reversible dementia with myoclonus due to concurrent HSV-2 and syphilis central nervous system infection in an immunocompetent man.

      Robles L, Anand A, Kass J

    • Zung Self Rating Depression Scale in Parkinson's disease: A validity study in veterans.

      Sarwar A, Hirshkowitz M

    • Clinical manifestations of tolerance to deep brain stimulation.

      Shah DP, Jimenez-Shahed J

    • Delayed diagnosis of brachial plexus neurolymphomatosis in post-transplant patient with diffuse large b-cell lymphoma.

      Stosic M, Tummala S

    • Mentored peer review of standardized manuscripts for teaching neurology residents biostatistics, research methodology, and peer review.

      Strowd RE, Wong VSS, Aragón García R, Haut S, Kass J, Mays MA, et al.

    • Clinical significance of abnormal electrode impedance readings in deep brain stimulation for treatment of movement disorders.

      Waln O, Jimenez-Shahed J

    • Dopamine transporter imaging in essential tremor with and without parkinsonian features.

      Waln O, Wu Y, Perlman R, Van AK, Wendt J, Jankovic J

    • Hereditary spastic paraplegia due to a novel mutation in SPG11 gene presenting as dopa responsive dystonia, parkinsonism and spasticity.

      Wijemanne S, Jankovic J

    • Concurrent bilateral Vim and STN DBS in a patient with ET/PD.

      Wijemanne S, Waln O, Jimenez-Shahed J

    • Resource utilization in patients with suspected psychogenic non epileptic seizures and drug resistant epilepsy in the Harris County Health District between 2009 and 2012.

      Wolf B, Hayashi B, Sachs E, Van Hook C, Murphey D, Goldsmith C

    International Neuropsychological Society (INS)
    42nd Annual Meeting in Seattle, Wash. (Feb. 12-15, 2014)

    • Progression and stability of cognitive asymmetry in a large sample of Alzheimer's disease patients.

      Alverson WA, Massman PJ, Grabyan JM, Doody RS

    • Perceived competency and quality of life deficits in individuals experiencing psychogenic non-epileptic events.

      Collins R, Robinson J, Plasencia M, Franks R, Chen D

    American Stroke Association
    2014 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2014)

    • ICD-9 code positive predictive value for stroke subtype in a population-based epidemiology study.

      Alwell K, Khoury JC, Kleindorfer DO, Moomaw CJ, Eilerman J, Woo D, et al.

    • Use of emergency medical services by stroke patients.
      [Oral Presentation]

      Anderson AM, Sucharew H, Alwell K, Moomaw CJ, Adeoye O, Woo D, et al.

    • Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis.

      Barreto AD, Mandava P, Guerrero W, Shen L, Grotta JC, Kent TA

    • Long term survival and hospital re-admission rates in elderly patients with subarachnoid hemorrhage treated with surgical or endovascular treatment.

      Chaudhry SA, Georgiadis AL, Qureshi AI, Qureshi Z

    • Prevalence of echocardiographic abnormalities in acute ischemic stroke.

      Eckerle B, Sucharew H, Alwell K, Moomaw CJ, Flaherty M, Martini S, et al.

    • Impact of substance abuse on timely treatment with rt-PA: A population-based study.

      Goodall EB, Kimmel PL, Sucharew H, Alwell K, Moomaw CJ, de los Rios La Rosa F, et al.

    • Prevalence of unsuspected renal insufficiency in stroke patients presenting to the emergency department: A population-based assessment.
      [Oral Presentation]

      Grossman AW, Khoury JC, Alwell K, Moomaw CJ, Khatri P, Woo D, et al.

    • Predictors of platelet transfusion in patients with intracerebral hemorrhage.

      Guerrero WR, Gonzales NR, Sekar P, Castillo J, Moomaw CJ, Worrall BB, et al.

    • Stroke in the young: Preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
      [Oral Presentation]

      Kissela BM, Alwell K, Khoury J, Moomaw C, Woo D, Adeoye O, et al.

    • Temporal trends in stroke incidence over the past twenty years: Stroke incidence has stabilized, racial disparity is not improving.

      Kleindorfer D, Alwell K, Khoury J, Moomaw CJ, Woo D, Adeoye O, et al.

    • Moderate alcohol use protects from intracerebral hemorrhage: Findings from the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Koch S, Brown MW, Moomaw CJ, Langefeld CD, Martini SR, Braimah J, et al.

    • Migraine and risk of intracerebral hemorrhage in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Koch S, Elkind MS, Moomaw CJ, Brown MW, Martini SR, Osborne J, et al.

    • Racial-ethnic blood pressure differences in acute intracerebral hemorrhage.
      [Oral Presentation]

      Koch S, Elkind MS, Testai FD, Brown MW, Martini SR, Sheth KN, et al.

    • Does intraventricular hemorrhage lead to a normal pressure hydrocephalus-like syndrome?

      Kruger AJ, Flaherty M, Sekar P, Haverbusch M, Moomaw CJ, Martini S, et al.

    • Stroke recurrence rates are not changing over time.
      [Oral Presentation]

      Lee I, Sucharew H, Alwell K, Moomaw CJ, Woo D, Ferioli S, et al.

    • A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke.

      Mandava P, Shah SD, Sarma AK, Dalmeida D, Kent TA

    • Improving quality of care and outcomes in the community through the inclusive collaboration between a certified comprehensive stroke center and regional hospitals.

      Mazabob JM, Styron S, Brown G, Jones-Brown M, Suarez J, Bershad E, et al.

    • Clinical outcomes following thrombolysis for acute ischemic stroke in patients with systemic malignancy: A nationwide case-control study.

      Murthy S, Karanth S, Shah S, Shastri A, Rao C, Bershad E, et al.

    • Clinical outcomes following thrombolysis for acute ischemic stroke in patients with primary brain tumors: A nationwide population study.

      Murthy SB, Shah S, Karanth S, Shastri A, Bershad E, Suarez JI

    • Treatment of ischemic stroke with recombinant tissue plasminogen-activator in pregnancy: A population study.

      Shah S, Murthy S, Karanth S, Bershad EM, Venkatasubba Rao CP, Suarez J

    • ICH & FUNC scores in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Sheth KN, Sung G, Langefeld CD, Moomaw CJ, Osborne J, Elkind MSV, et al.

    • Prior use of statins may reduce hematoma growth in intracerebral hemorrhage patients.

      Siddiqui FM, Olson DM, Sekar P, Moomaw CJ, Rosand J, Kidwell C, et al.

    • Utilization of vascular imaging in stroke: A population based study.

      Vagal A, Sucharew H, Alwell K, Khoury J, Khatri P, Woo D, et al.

    • Is obesity a marker of good or bad functional outcome after ischemic stroke?

      Yeramaneni S, Kissela BM, Kleindorfer DO, Alwell K, Moomaw CJ, McCarthy M, et al.

2013

Collapse All | Expand All

 

2012

Collapse All | Expand All

 

    American Epilepsy Society (AES)
    66th Annual Meeting in San Diego, Calif. (Nov. 30 - Dec. 4, 2012)

    • SUDEP Tissue Donation Program (STOP): Collaborative network in support of SUDEP registry, tissue repository and human translational research.

      Goldman AM

    • Myotonia in brain: 'Skeletal' chloride channel ClC-1 linked to idiopathic generalized epilepsy with focal myotonia.

      Klassen TL, Chen TT, Reed JG, Kole MJ, Goldman AM, Marini C, et al.

    • An abbreviated support group therapy for psychogenic nonepileptic events: A neurologist-initated program in an epilepsy center.

      Maheshwari A, Trolley G, Franks R, Chen DK

    National Academy of Neuropsychology (NAN)
    32nd Annual Meeting in Nashville, Tenn. (Nov. 7-10, 2012)

    • Mexican American normative references on tasks of memory and language: The Texas Mexican American normative studies.

      Edwards M, Balldin V, Hall J, Strutt A, Pavlik V, Marquez de la Plata C, et al.

    • Normative data for Mexican American on tasks of executive and physiometric functions: The Texas Mexican American normative studies.

      Hall J, Edwards M, Balldin V, Strutt A, Pavlik V, Marquez de la Plata C, et al.

    • Normative performance on the RBANS in a multi-ethnic bilingual cohort: The Texas Mexican American normative studies.

      Hobson Balldin V, Menon C, Younes S, Hall J, Strutt A, Pavlik V, et al.

    • Adaptation and norming of the Boston Naming Test for Spanish-speaking older adults in the USA.

      Resendiz C, Scott B, Farias G, York M, Lozano V, Mahoney M, et al.

    Baylor College of Medicine (BCM)
    Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012)

    Society for Neuroscience (SFN)
    42nd Annual Meeting in New Orleans, La. (Oct. 13-17, 2012)

    • Neuronal Elavl proteins regulate RNA splicing and abundance to control brain glutaminase expression and neuronal excitability.

      Ince Dunn G, Okana HJ, Okana H, Jensen K, Park W-Y, Mele A, et al.

    • Visualization of the population receptive field structures in human visual cortex.

      Lee S, Keliris GA, Papanikolaou A, Smirnakis SM, Logothetis NK

    • 4-Aminopyrindine preferentially augments Cav1.2 activity and promotes Cavα1 membrane traffic by acting at HOOK region of Cavβ3 subunit.

      Li L, Cao XH, Chen SR, Li DP, Hu HZ, Snutch TP, et al.

    • Impact of single cell firing on in vivo cortical activity.

      Meyer JF, Golshani P, Smirnakis SM

    • Pattern motion and direction selectivity in mouse V1.

      Palagina GS, Torsky S, Smirnakis SM

    • Population activity in the motor cortex of the MeCP2 duplication mouse.

      Suter B, Meyer JFH, Ash RT, Zoghbi HY, Smirnakis SM

    World Stroke Organization (WSO)
    8th World Stroke Congress in Brasilia, Brazil (Oct. 10-13, 2012)

    American Neurological Association (ANA)
    137th Annual Meeting in Boston, Mass. (Oct. 7-9, 2012)

    • Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington disease.

      Fekete R, Davidson A, Jankovic J

    • A prospective, observational trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of CD on patients using the cervical dystonia impact profile (CDIP).

      Jankovic J, Thomas M, Vasquez A, Sethi KD, Verma A, Pappert EJ, et al.

    • A prospective, observational trial evaluating Xeomin [IncobotulinumtoxinA] for cervical dystonia or blepharospasm in the US - Preliminary baseline results for patients with blepharospasm.

      LeDoux MS, Jankovic J, Sethi KD, Verma A, Pappert EJ, Fernandez HH

    • Mutations in the novel protein PRRT2 cause infantile convulsions with paroxysmal kinesigenic dyskinesia.

      Lee H-Y, Huang Y, Bruneau N, Roll P, Roberson EDO, Hermann M, et al.

    • Protective association between ACE inhibitors and lobar intracerebral hemorrhage.

      Martini SR, Flaherty ML, Brown WM, Moomaw CJ, Comeau ME, Haverbusch M, et al.

    • Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.

      Moretti P, McCauley S, Wilde E, Levin H

    • Genetic susceptibility for amyloid pathology in Alzheimer's disease.

      Shulman JM, Chen K, Keenan BT, Chibnik LB, Thiyyagura P, McCabe C, et al.

    • Integrating human and fly genetics to understand Alzheimer's disease susceptibility.

      Shulman JM, Imboywa S, Diamond AE, Chipendo P, De Jager PL, Feany MB

    • Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
      [Platform Presentation]

      Szigeti K, Lal D, Li Y, Doody RS, Yan L

    • Subacute combine degeneration of the cord due to functional B12 deficiency.

      Wijemanne S, Li S, Vytopil M

    • Incidence of Lewy body negative parkinsonism in a community based sample.

      Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

    • Inclusion of axial rigidity may improve diagnostic accuracy for dementia with Lewy bodies.

      Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

    Neurocritical Care Society (NCS)
    10th Annual Meeting in Denver, Colo. (Oct. 4-7, 2012)

    • Prior statin use reduces rate of delayed cerebral ischemia after subarachnoid hemorrhage.

      Abhishek F, Damani R, Mohamed W, Suchdev K, Varade P, Atkinson B, et al.

    • Post t-PA care for acute stroke patients: comparison between intensive care unit admission and stroke unit admission.

      Chalela JA, Steffen C, Gay SE, Hill M, Andrews C, Neyens R, et al.

    • Angiogramp-negative subarachnoid hemorrhage (aN-SAH): Not as benign as you would think.

      Damani R, Abhishek F, Mohamed W, Suchdev K, Varade P, Norris G, et al.

    • Computed tomography pulmonary angiography: does it tell us more than we think?

      Eriksson E, Rickey A, Leon S, Lazaridis C, Rickey J, Minshall C

    • Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.

      Hannawi Y, Shah S, Bershad EM, Suarez JI, Shaltoni HM, Yoshor D, et al.

    • Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA.
      [Platform Presentation]

      Mandava P, Shah S, Murthy SB, Kent TA

    • Comparing perfusion computed tomography to digital subtraction angiography in detecting delayed cerebral ischemia.

      Mohamed W, Varade P, Damani R, Abhishek F, Suchdev K, Norris G, et al.

    • The utility of DynaCT in evaluation of subarachnoid hemorrhage: A case report.

      Shah S, Hannawi Y, Urfy MZ, Venkatasubba Rao CP

    Alzheimer's Association International Conference (AAIC)
    Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012)

    AREADNE Foundation, Inc.
    Conference in Santorini, Greece (June 21-24, 2012)

    • Population receptive field mapping in human subjects after lesions of the visual pathway.

      Papanikolaou A, Keliris GA, Papageorgiou DT, Shao Y, Krapp E, Schiefer U, et al.

    • Population receptive field measurements in the visual cortex of macaque monkeys.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jaegle H, et al.

    Movement Disorder Society (MDS)
    16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland (June 17-21, 2012)

    Vision Sciences Society (VSS)
    12th Annual Meeting in Naples, Fla. (May 11-16, 2012)

    • Population receptive field measurements in macaque visual cortex.
      [Platform Presentation]

      Smirnakis SM, Keliris GA, Shao Y, Papanikolaou A, Logothetis NK

    Parkinson Study Group (PSG)
    26th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012)

    American Academy of Neurology (AAN)
    64th Annual Meeting in New Orleans, La. (April 21-28, 2012)

    Boston Society of Neurology and Psychiatry (BSNP)
    Stanley Cobb Assembly in Boston, Mass. (March 2012)

    • Case of Wernicke's encephalopathy presenting as a frontal lobe syndrome.

      Wijemanne S, Parkerson K, Sabin T

    International Neuropsychological Society (INS)
    40th Annual Meeting in Montreal, Quebec, Canada (Feb. 15-18, 2012)

    American Clinical Neurophysiology Society (ACNS)
    2012 Annual Meeting in San Antonio, Texas (Feb. 7-12, 2012)

    • Can EEG sampling be used as an effective tool for detecting clinically significant seizures?

      Pacheco V, Cherian V, Izadyar S, Hrachovy R

    American Stroke Association
    2012 International Stroke Conference in New Orleans, La. (Feb. 1-3, 2012)

    • Has patient selection for carotid endarterectomy and stenting changed over time? Carotid revascularization in the post CREST era.

      Bhattacharya P, Damani R, Rayes M, Chaturvedi S

    • Carotid revascularization in elderly asymptomatic patients: Are the results optimal?

      Damani R, Rayes M, Bhattacharya P, Chaturvedi S

    • A comparison of carotid artery stent placement performed within and outside clinical trials in the United States.
      [Platform Presentation]

      Hussein HM, Chaudhry SA, Majidi S, Khatri R, Rodriguez GJ, Suri MFK, et al.

    • Reliability of hematoma volume calculation at local sites in the setting of a multicenter intracerebral hemorrhage clinical trial.

      Hussein HM, Tariq N, Qureshi AI

    • Antioxidant carbon-based nanomaterials: In-vitroprotection and in-vivo effects on the neurovascular unit.

      Kent TA, Bitner BR, Berlin JM, Robertson CR, Marcano DC, Fabian RH, et al.

    • Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling.

      Krumpelman CS, Mandava P, Kent TA

    • A new more sensitive method to assess balance among stroke trial populations.

      Mandava P, Brooks ME, Krumpelman CS, Kent TA

    • A systematic analysis of endovascular and intravenous therapy for ischemic stroke based on time window using a novel outcome model.

      Mandava P, Shah S, Sarma AK, Murthy SB, Kent TA

    • Pre-procedural international normalized ratio and hemorrhagic complications associated with neurointerventional procedures.

      Martin AD, Chaudhry SA, Kainth H, Hussein HM, Rodriguez GJ, Suri MFK, et al.

    • Differential effect of high cholesterol by intracerebral hemorrhage location.
      [Moderated Poster]

      Martini SR, Brown WM, Comeau ME, Flaherty M, Haverbusch M, Moomaw C, et al.

    • Protocol for rapid acquisition and interpretation of head CT in acute stroke patients eligible for thrombolysis.

      Mazabob JM, Brown G, Livesay S, Nguyen T, Hu B-B, Suarez J, et al.

    • Contrast induced nephropathy is associated with poor outcomes in IV t-PA treated patients.

      Mir O, Wu T-C, Saenz D, Peng H, Grotta JC, Savitz S

    • Factors associated with individual variations in systolic blood pressure responsive to intravenous antihypertensive medication. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study.

      Qureshi AI, Palesch YY, Martin R, Novitzke J, Flores SC, Ehtisham A, et al.

    • Rate of inappropriate statin use after intracerebral hemorrhage.

      Woo D, Comeau M, Flaherty ML, Brown M, Haverbusch M, Moomaw C, et al.

    2011 International Society for Zinc Biology (ISZB)
    Meeting in Melbourne, Australia (Jan. 15-19, 2012)

    • Intracellular dialysis can be exploited to distinguish sources of intracellular Zn2+ accumulation in hippocampal neurons.

      Aiba I, Shuttleworth CW

    Biochemical Society
    Conference: The biology and pathology of tau and its role in tauopathies II in Cambridge, U.K. (Jan. 8-9, 2012)

    • Dissection of tauopathy mechanisms using unbiased genetic screening in the Drosophila retina.
      [Invited Plenary Speaker]

      Jackson GR

    Cambridge University
    Academic division of Neurosurgery, Research Seminar in Cambridge, UK (2012)

    • Critical ICP in severe TBI.
      [Invited Talk]

      Lazaridis C

    Henry Ford Hospital and University
    Detroit, Mich. (2012)

    • Advanced hemodynamic monitoring in neurocritical care.
      [Invited Talk, Division of Neurocritical Care]

      Lazaridis C

    Medical University of South Carolina
    Charleston, S.C. (2012)

    • Cerebral blood flow regulation: inside and outside the operating room.
      [Anesthesiology/Critical Care and Perioperative Medicine Grand Rounds]

      Lazaridis C

    • Optimal CPP, individualized ICP.
      [Neuroscience Grand Rounds]

      Lazaridis C

    Medical University of South Carolina, U.S. Army Medical Research and Materiel Command, and the Telemedicine & Advanced Technology Research Center
    Charleston, S.C. (2012)

    • Critical care for ischemic stroke.
      [CME program for physicians state-wide in South Carolina]

      Lazaridis C

<2011

Collapse All | Expand All

 

    American Epilepsy Society (AES)
    65th Annual Meeting in Baltimore, Md. (Dec. 2-6, 2011)

    • Does memory test performance have localizing significance in pediatric epilepsy?

      Chapieski L, Agadi S, Evankovich K, Collins R, Riviello J, Schultz R, et al.

    • Intact vs. impaired ictal sensorium: Does it affect outcome of psychogenic nonepileptic events following disclosure of diagnosis.

      Izadyar S, Franks R, Chen DK, Hrachovy RA

    • Dendritic AMPA receptor deficit on cortical interneurons in the stargazer mouse model of absence epilepsy.

      Maheshwari A, Reed JG, Noebels JL

    • Steroid-responsive encephalopathy due to autoimmune thyroiditis presenting as epilepsia partialis continua: a case report.

      Pulicken M, Wijemanne S, Drobnis A, Thaler DE, Parkerson KA

    Society for Neuroscience (SFN)
    41st Annual Meeting in Washington, DC (Nov. 12-16, 2011)

    • NMDA receptor activation prolongs the duration of ionic dyshomeostasis following spreading depolarization in murine brain slices.

      Aiba I, Shuttleworth CW

    • Blue cheese/Alfy affects autophagy activation and tau toxicity in a Drosophila model of tauopathy.

      Bakhoum MF, Jackson GR

    • Propagation of spreading depolarizations is limited by the synaptic release and extracellular actions of Zn2+.

      Carter RE, Aiba I, Carlson AP, Sheline CT, Shuttleworth CW

    • Flupirtine reverses hyperexcitability in Kv1.1 potassium channel deficient myelinated vagal axons.

      Glasscock E, Qian J, Kole MJ, Noebels JL

    • Tau loss regulates excitability in mouse and Drosophila genetic models of epilepsy.

      Holth J, Reed JG, Inoue T, Pautler R, Botas J, Noebels J

    • RNA binding protein hnRNP K/bancal and its intronic microRNA miR-7 exert opposite effects on tau toxicity through regulation of Insulin Receptor Substrate/chico and GSK-3beta activity.

      Jackson GR, Ambegaokar S

    • ADAM11 is responsible for trafficking of Kv1 subunits to cerebellar basket cell terminals.

      Kole MJ, Waase MP, Klassen TL, Chen TT, Breslow JL, Noebels JL

    • Targeting voltage gated calcium channel β3 subunit to treat neuropathic pain.

      Li L, Cao XH, Chen SR, Pan HL

    • Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia.

      Mark MD, Maejima T, Kuckelsberg D, Woo JW, Hyde RA, Shah V, et al.

    • Early 17-beta-estradiol treatment decreases seizure and interictal spike frequency in the ARX(GCG)10+7 genetic mouse model of X-linked infantile spasms.

      Olivetti PR, Noebels JL

    • Population receptive field mapping in human subjects with lesions of the visual cortex.

      Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

    • Transformation of visual sensory information from cortical layer 4 to layer 2/3: The second stage of visual cortical processing.

      Polack P-O, Chow D, Sharim J, Friedman J, Gruver R, Smirnakis S, et al.

    • Horizontal and vertical eye movements in huntington's disease patients and age matched controls.

      Red S, Ing J, Jeter CB, Hood AJ, Patel SS, Jankovic J, et al.

    • Population receptive field measurements in visual cortex of macaque monkeys.

      Shao Y, Keliris GA, Papanikolaou A, Augath M, Logothetis NK, Smirnakis SM

    • Suppression of the protein kinase PKR promotes network hypersynchrony and enhanced cognition.

      Zhu P, Huang W, Kalikulov D, Yoo J, Placzek A, Stoica L, et al.

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    41st Biennial Convention in Grapevine, Texas (Oct. 29 - Nov. 2, 2011)

    • Evaluation of video teleconferencing technology to provide chronic disease self-management access for rural veterans.

      Anderson J, Willson P

    American Neurological Association (ANA)
    136th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)

    • Comparison of subthalamic (STN) and pallidal (GPI) deep brain stimulation (DBS) on gait and balance in patients with Parkinson's disease (PD).

      Hou JG, Thant M, Sarwar A, Fincher L, Bryant MS, Atassi F, et al.

    • Association of PSP with chemical occupational exposure factors.

      Litvan I, Cunningham CR, Lees P, Jackson L, Juncos J, Riley D, et al.

    • Neurological outcome scale for traumatic brain injury: Predictive validity and sensitivity to change.

      Moretti P, McCauley SR, Wilde EA, Scott JN, Clifton GL

    • Standardized sign out improves communication skills.

      Moseley BD, Smith JH, Diaz-Medina GE, Paz Soldan M, Wicklund M, Dhamija R, et al.

    • Visuospatial construction measures and their utility in identifying dementia of the Alzheimer's type.

      Scott BM, Duncan G, Carlson H, Nance M, York MK, Larery A, et al.

    • Integrating genome-wide association and functional validation to understand susceptibility for Alzeheimer's pathology.
      [Platform Presentation]

      Shulman JM, Chipendo PI, Chibnik LB, Keenan BT, Tran D, Huentelman MA, et al.

    Neurocritical Care Society (NCS)
    9th Annual Meeting in Montreal, Quebec, Canada (Sept. 21-24, 2011)

    • Clinical utility of continuous electroencephalogram (CEEG) monitoring in hypothermia after cardiac arrest.

      Livesay S, Bershad E, Suarez J, Hrachovy R, Manian P, Herlihy JP, et al.

    • The neurocritical care research network: Building an international research infrastructure.

      Suarez JI, LeRoux PD, Geocadin R, Wijman C

    • Albumin in subarachnoid hemorrhage: The ALISAH pilot study results.

      Suarez JI, Martin RH, Calvillo E

    Michael J. Fox Parkinson's Research Foundation
    Genetic Epidemiology of Parkinson's Disease Consortium Meetiing in Evanston, Ill. (Sept. 18-21, 2011)

    • What can endophenotypes teach us about Parkinson's disease?
      [Oral Presentation]

      Shulman JM

    European Federation of Neurological Societies (EFNS)
    15th Congress in Budapest, Hungary (Sept. 10-13, 2011)

    • A systematic analysis of intravenous and endovascular therapy for ischemic stroke using a novel predictive outcome model.

      Mandava P, Sarma AK, Shah S, Kent TA

    • Sustained efficacy of long-term incobotulinumtoxin-a (Xeomin®; botulinum neurotoxin type-a, free from accessory proteins) treatment for cervical dystonia, blepharospasm and upper limb post-stroke spasticity.

      Truong DD, Brodsky MA, LeWitt PA, Gollomp SM, Kanovsky P, Pulte I, et al.

    2011 International Conference on Alzheimer's Disease (ICAD)
    Paris, France (July 16-21, 2011)

    • Serum granulocyte colony stimulating factor and Alzheimer's disease.

      Barber R, O'Bryant S, Reisch J, Doody R, Fairchild T, Adams P, et al.

    • The impact of depression on cognition varies by APOE4 status.

      Dentino A, Hall J, Barber R, Doody R, Royall D, O'Bryant S

    • Biomarkers associated with cardiovascular risk in the Texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and homocysteine.

      Doody R, Chan W, Ballantyne C, Pavlik V, Barber R, O'Bryant S, et al.

    • Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort.

      Doody R, Chan W, Barber R, Ballantyne C, Pavlik V, O'Bryant S, et al.

    • A candidate causal variant in the CR1 locus.

      Keenan B, Shulman J, Chibnik L, Corneveaux J, Allen A, Myers A, et al.

    • Plasma sphingomyelin is associated with cognitive progression in Alzheimer's disease.

      Mielke M, Haughey N, Bandaru VVR, Weinberg D, Zaidi N, Pavlik V, et al.

    • Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease.

      O'Bryant S, Xiao G, Barber R, Hall J, Doody R, Reisch J, et al.

    • A serum protein-based algorithm for the detection of Alzheimer's disease.

      O'Bryant S, Xiao G, Robert B, Hall J, Doody R, Reisch J, et al.

    • Racial/ethnic group differences in the association of APOE ε4 genotype and visuospatial test performance in a non-demented sample.

      Pavlik V, Massman P, Rustveld L, Doody R

    • Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression.

      Raj T, Shulman J, Chibnik L, Keenan B, Stranger B, Evans D, et al.

    • Factors that influence survival in Alzheimer's patients.

      Rountree S, Chan W, Pavlik V, Darby E, Doody R

    • The cognitive correlates of functional status: a new approach to dementia.

      Royall DR, Doody R, Barber R, Palmer R, O'Bryant S, Reisch J, et al.

    • Genetic factors associated with the rate of cognitive decline in Alzheimer's disease.

      Sherva R, Tripodis Y, Shulman J, Chibnik L, Crane P, Bennett D, et al.

    • A genome-wide association scan for episodic memory decline in aging.

      Shulman J, Chibnik L, Keenan B, Destefano A, Leurgans S, Wilson R, et al.

    • Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
      [Platform Presentation]

      Shulman J, Chipendo P, Chibnik L, Keenan B, Tran D, Aubin C, et al.

    • Genome-wide association scan replication for biomarker endophenotypes of Alzheimer's disease.

      Wilhelmsen K, Chasse S, Griffin N, Diaz-Arrastia R, Barber R, Royall D, et al.

    • Developing and validating of diagnostic algorithm for Alzheimer's disease.

      Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, et al.

    Gordon Research Conferences
    Excitatory Synapses & Brain Function Meeting in Easton, Mass. (June 26 - July 1, 2011)

    • NMDA-R activation contributes to metabolic burden following spreading depolarization in murine hippocampal slices.

      Aiba I, Shuttleworth CW

    Movement Disorder Society (MDS)
    15th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada (June 5-9, 2011)

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2011, 25th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Barcelona, Spain (May 25-28, 2011)

    • Antioxidant carbon nanotubes: In-vitro characterization and in-vivo effects on cerebrovascular regulation.

      Kent TA, Bitner BR, Berlin JB, Marcado D, Robertson CR, Fabian RH, et al.

    European Stroke Conference (ESC)
    20th Annual Meeting in Hamburg, Germany (May 24-27, 2011)

    • How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
      [Previously Presented]

      Mandava P, Sarma A, Anderson J, Wehner B, Kent T

    • Hyperglycemia is an independent risk factor for poor outcome after rtPA only in the large artery stroke subtype.

      Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

    • Novel analysis methodology indicates extended window low-dose IV abciximab improves outcome.

      Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

    American College of Physicians (ACP)
    Michigan Chapter Scientific Meeting in Ann Arbor, Mich. (May 20, 2011)

    • A case report of cryptosporidium diagnosed by small bowel biopsy in an AIDS patient.

      Hiploylee J, Damani R, Khokhar S

    American Heart Association
    2011 Quality of Care and Outcomes Research Meeting (QCOR) in Washington, D.C. (May 12-14, 2011)

    • Mind the time: a quality improvement project to increase the percent of ischemic stroke patients receiving intravenous t-PA within 60 minutes after emergency department arrival.

      Mazabob J, Livesay S, Meade A, Brown G, Suarez JI, Bershad EM, et al.

    Plasticise
    2nd Annual Meeting in Stresa, Italy (May 4-6, 2011)

    • Population receptive field mapping in human subjects with visual cortical lesions.

      Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

    • Population receptive field measurements in a macaque monkey with macular degeneration.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Jaegle H, Seeliger MW, et al.

    Association for Research in Vision and Ophthalmology (ARVO)
    2011 Annual Meeting in Fort Lauderdale, Fla. (May 1-5, 2011)

    • Analysis of corneal biomechanical properties in patients with exfoliation syndrome and exfoliative glaucoma.

      Prata TS, De Moraes GV, Anand A, Tello C, Liebmann JM, Ritch R

    • Use of amniotic membrane graft in glaucoma shunt surgery.

      Sheha H, Anand A, Tello C

    American Academy of Neurology (AAN)
    63rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)

    Genetics Society of America (GSA)
    52nd Annual Drosophila Research Conference in San Diego, Calif. (March 30 - April 3, 2011)

    • dEHBP1 regulates Notch mediated lateral inhibition in the Drosophila eye.

      Giagtzoglou N, Li T, Bellen H

    • dEHBP1 regulates endocytosis and active zone assembly at the developing neuromuscular junction.
      [Platform Presentation]

      Giagtzoglou N, Lin YQ, Haueter C, Bellen H

    • dEHBP1 affects Notch signaling by impairing Delta trafficking during asymmetric divisions.

      Giagtzoglou N, Yamamoto S, Zitserman D, Groves H, Klein H, Schulze K, et al.

    • Defects in peroxisomal biogenesis lead to age-dependent locomotor deficits and retinal dysfunction in Drosophila.

      Wangler M, Bayat V, Giagtzoglou N, Haueter C, Bellen H

    Boston Society of Neurology and Psychiatry (BSNP)
    Stanley Cobb Assembly in Boston, Mass. (March 16, 2011)

    • Cerebral hemosiderosis due to spinal dural tract.

      Wijemanne S, Gorson K

    AD/PD
    10th International Congress on Alzheimer's and Parkinson's Diseases in Barcelona, Spain (March 9-13, 2011)

    Keystone Symposium
    Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011)

    • Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
      [Platform Presentation]

      Shulman JM

    Texas Scottish Rite Hospital for Children
    33rd Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 17-18, 2011)

    American Stroke Association
    2011 International Stroke Conference in Los Angeles, Calif. (Feb. 8-11, 2011)

    • Implementation of the American Stroke Association Sharegiver Program (Peer Support).

      Damush TM, Anderson J, Nicholas G, Kimmel B, Kent T, Williams LS

    • Aggressive blood pressure control with clevedipine in patients with acute intracerebral hemorrhage is rapid and well tolerated: the ACCELERATE trial.

      Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, LaPointe M, et al.

    • Is the risk of fatal brain edema increased with thrombolysis among patients with acute ischemic stroke?

      Hussein HM, Chaudhry SA, Asaithambi G, Thomson R, Sultan F, Taylor RA, et al.

    • Clinical relevance of residual stenosis following intracranial angioplasty and/or stent placement for atherosclerotic lesions.
      [Platform Presentation]

      Hussein HM, Chaudry S, Tariq N, Miley JT, Suri MFK, Taylor RA, et al.

    • Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype.

      Mandava P, Munoz M, Dalmeida W, Sarma K, Brooks MA, Anderson J, et al.

    • Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.

      Mandava P, Munoz M, Sarma K, Brooks MA, Dalmeida W, Anderson J, et al.

    • The ALISAH study: a dose escalation and safety study of 25% human albumin therapy in subarachnoid hemorrhage — outcome results and treatment effects.

      Martin RL, Suarez JI, and the ALISAH Study Investigators

    • A multidisciplinary quality imporvement project to address delays in CT imaging and thrombolytic treatment in acute stroke patients.

      Mazabob JM, Brown G, Stewart P, Livesay S, Freeborg S, Suarez JI, et al.

    • The ALISAH Study: a dose escalation and safety study of 25% human albumin therapy in subarachnoid hemorrhage — Safety results and physiologic response.

      Suarez JI, Martin RL, and the ALISAH Study Investigators

    • Comparison of acute medical treatments in ischemic stroke patients aged 80 years or older.

      Zacharatos H, Hassan AE, Vazquez G, Hussein HM, Rodriguez GJ, Suri MFK, et al.

    International Neuropsychological Society (INS)
    39th Annual Meeting in Boston, Mass. (Feb. 2-5, 2011)

    Medical University of South Carolina
    Charleston, S.C. (2011)

    • Brain tissue oxygenation.
      [Critical Care Grand Rounds]

      Lazaridis C

    Rush University
    ROS/MAP Investigator Meeting in Chicago, Ill. (2011)

    • Genomics of cognitive decline and neuropathology.
      [Oral Presentation]

      Shulman JM

    2010 American Society for Cell Biology (ASCB)
    Annual Meeting in Philadelphia, Penn. (Dec. 11-15, 2010)

    • An unbiased genetic screen for modifiers of tauopathy using both loss and gain of function approaches.

      Jackson GR, Ambegaokar S

    American Epilepsy Society (AES)
    64th Annual Meeting in San Antonio, Texas (Dec. 3-7, 2010)

    Society for Neuroscience (SFN)
    40th Annual Meeting in San Diego, Calif. (Nov. 13-17, 2010)

    • Metabolic dependence of zinc effects on spreading depression in murine brain slices.

      Aiba I, Shuttleworth CW

    • Modulation of tau oligomers by passive vaccination.

      Castillo DL, Lasagna-Reeves C, Guerrero-Munoz MJ, Estes DM, Barrett A, Dineley K, et al.

    • MeCP2 deficiency in GABAergic neurons recapitulates Rett syndrome phenotypes.

      Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, et al.

    • Characterization of tau oligomers in Alzheimer's disease.

      Kayed R, Lasagna-Reeves C, Guerrero-Munoz M, Sengupta U, Troncoso J, Jackson GR

    • Assessing the spatio-temporal dynamics of visual receptive fields by fMRI.

      Keliris GA, Shao Y, Papanikolaou A, Peng X, Logothetis K, Smirnakis SM

    • Population receptive field mapping in human subjects with visual cortical lesions.

      Papanikolaou A, Keliris GA, Peng X, Shao Y, Krapp E, Papageorgiou E, et al.

    • Synergistic effects of tau and alpha-synuclein in dopaminergic neurons.

      Roy B, Ambegaokar SS, Jackson GR

    • Tau oligomers in Parkinson disease and dementia with Lewy bodies and their connection with alpha-synuclein oligomers.

      Sengupta U, Lasagna-Reeves C, Guerrero-Munoz M, Castillo-Carranza D, Jackson GR, Troncoso J, et al.

    • Population receptive field mapping in a macaque monkey with macular degeneration.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jägle H, et al.

    American Society of Human Genetics (ASHG)
    60th Annual Meeting in Washington, DC (Nov. 2-6, 2010)

    • Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
      [Platform Presentation]

      Shulman JM, Chipendo1 P, Aubin C, Kramer P, Schneider JA, Bennett DA, et al.

    Neurocritical Care Society (NCS)
    8th Annual Meeting in San Francisco, Calif. (Sept. 15-18, 2010)

    • Predicting critical care needs in stroke patients receiving intravenous thrombolysis.
      [Platform Presentation]

      Chalela J, Koval K, Jauch E, Neyens R, Hays A, Lazaridis C

    • Effects of aggressive blood pressure reduction on hematoma volume in acute intracerebral hemorrhage: an analysis from the ACCELERATE trial (a single-arm, open-label study of clevidipine).

      Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, Lapointe M, et al.

    • Osmotherapy in clinical practice: a survey of practitioners.

      Hays A, Lazaridis C, Neyens R, Nicholas J, Gay S, Chalela J

    • Red blood cell transfusion in aneurysmal subarachnoid hemorrhage patients: A multidisciplinary North American survey.

      Kramer A, Diringer M, Naidech A, Macdonald L, LeRoux P, Suarez J

    • Cerebral blood flow velocity and pulsatility index changes post decompressive craniectomy.

      Lazaridis C, DeSantis S, Mullins T, Harmon S, Chalela J

    • General trauma.
      [Neurocritical Care: Certification Review Course]

      Lazaridis C, Ling GS

    • Neurotrauma.
      [Neurocritical Care: Certification Review Course]

      Ling GS, Lazaridis C

    • Neurocritical care morbidity and mortality (M&M): A multidisciplinary systems-based approach for improving patient care.

      Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

    • The neurocritical care telestroke network: Extending high quality care to the underserved community for reasonable cost.

      Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

    • Single brain death examination does not improve organ transplantation.

      Varelas P, Rao CV, Rehman M, Patel A, Rai V, Barber A, et al.

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    21st International Nursing Research Congress in Orlando, Fla. (July 12-16, 2010)

    • Chronic disease: Framework, education and practice.

      Anderson J, Willson P

    • Chronic disease: A telehealth Transition Assistance Program (TAP) for veteran caregivers.

      Willson P, Anderson J

    2010 International Conference on Alzheimer's Disease (ICAD)
    Honolulu, Hawaii (July 10-15, 2010)

    European Neurological Society (ENS)
    20th Annual Meeting in Berlin, Germany (June 19-23, 2010)

    Movement Disorder Society (MDS)
    14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010)

    Organization of Human Brain Mapping (OHBM)
    16th International Conference in Barcelona, Spain (June 6-10, 2010)

    • Classification accuracy and spatial networks of motion coherence and direction using real-time fMRI.

      Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

    Consortium of Multiple Sclerosis Centers (CMSC)
    24th Annual Meeting in San Antonio, Texas (June 2-5, 2010)

    European Stroke Conference (ESC)
    19th Annual Meeting in Barcelona, Spain (May 25-28, 2010)

    • Rebalancing the NINDS rt-PA trial.

      Mandava P, Kent TA

    Association for Research in Vision and Ophthalmology (ARVO)
    2010 Annual Meeting in Fort Lauderdale, Fla. (May 2-6, 2010)

    • Short-duration visual evoked potential as an objective tool for screening refractive errors.

      Anand A, De Moraes CG, Teng CC, Liebmann JM, Ritch R, Tello C

    American Academy of Neurology (AAN)
    62nd Annual Meeting in Toronto, Canada (April 10-17, 2010)

    Mayo Clinic
    Young Investigator Research Symposium in Rochester, Minn. (March 28-29, 2010)

    • Bilateral striopallidodentate calcinosis with paroxysmal kinesigenic dyskinesia.

      Diaz GE, Wirrell EC, Matsumoto JY, Krecke KN

    Howard Hughes Medical Institure (HHMI)
    Structural Plasticity in the Mammalian System Symposium at Janelia Farm in Chevy Chase, Md. (March 2010)

    • Visual cortex plasticity in adulthood: Why consensus remains elusive.
      [Platform Presentation]

      Smirnakis SM

    American Society for Neurochemistry (ASN)
    41st Annual Meeting in Santa Fe, N.M. (March 6-10, 2010)

    • Different roles of extracellular and intracellular Zn2+ in spreading depression-like events in hippocampal slice.

      Aiba I, Dietz RM, Sheline CT, Shuttleworth CW

    American Glaucoma Society (AGS)
    20th Annual Meeting in Naples, Fla. (March 4-7, 2010)

    • Corneal hysteresis and visual field asymmetry in open angle glaucoma.

      Anand A, De Moraes CG, Teng CC, Tello C, Liebmann JM, Ritch R

    Texas Scottish Rite Hospital for Children
    32nd Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 25-26, 2010)

    American Stroke Association
    2010 International Stroke Conference in San Antonio, Texas (Feb. 23-26, 2010)

    • No differential effect of tPA based on final stroke etiologic subtype: A reanalysis of the NINDS tPA trial.
      [Moderated Poster]

      Martini SR, Yeatts SD, Belagage SR, Khatri P

    • Comparison between thrombolytic bridging therapy and primary endovascular treatment in acute ischemic stroke: A multicenter study.

      Miley J, Vazquez G, Memon MZ, Hussein HM, Suri MFK, Taylor RA, et al.

    • Prominent loss of clinical benefit among patients with acute ischemic stroke treated with endovascular treatment after 6 hours of symptom onset.

      Miley J, Vazquez G, Memon MZ, Hussein HM, Suri MFK, Tummala RP, et al.

    • Does national institutes of health stroke scale score provide additional predictive value in good grade patients with intracerebral hemorrhage? Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study.
      [Platform Presentation]

      Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al.

    • Effect of serum glucose concentrations during acute hospitalization on hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study.

      Qureshi AI, Palesch YY, Martin R, Novitzke J, Cruz-Flores S, Ehtisham A, et al.

    • Factors associated with neurological complications following intracranial angioplasty and/or stent placement. A multicenter study.

      Qureshi AI, Tariq N, Hassan AE, Vazquez G, Hussein HM, Suri MF, et al.

    • Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.

      Suarez JI, for the ALISAH Investigators

    • Prevalence of asymptomatic intracranial stenosis in US elderly population: Results from the Ultrasound Screening in Adults for Intracranial Disease (USAID) study.

      Suri MFK, Tariq N, Georgiadis AL, Qureshi MH, Vazquez G, Qureshi MN, et al.

    • Transcranial doppler ultrasound for detecting intracranial stenosis in elderly population. Results from the Ultrasound Screening in Adults for Intracranial Disease (USAID) study.

      Suri MFK, Tariq N, Georgiadis AL, Qureshi MH, Vazquez G, Qureshi MN, et al.

    • Predictors and impact of hematoma resorption in medically treated patients with intracerebral hemorrhage.

      Tariq N, Hussein HM, Vazquez G, Martin R, Novitzke J, Suri MFK, et al.

    Baylor College of Medicine (BCM)
    20th Annual Rush and Helen Record Neuroscience Forum in Galveston, Texas (Feb. 19-21, 2010)

    International Neuropsychological Society (INS)
    38th Annual Meeting in Acapulco, Mexico (Feb. 3, 2010)

    Howard Hughes Medical Institure (HHMI)
    Science Meeting, Janelia Farm Research Center in Ashburn, Va. (2010)

    • dEHBP1 is a novel regulator of endocytosis in Notch signaling and in synaptic vesicle cycle.

      Giagtzoglou N, Yamamoto S, Qi LY, Haueter C, Bellen HJ

    Medical University of South Carolina
    Charleston, S.C. (2010)

    • Critical care for SAH.
      [Neurology and Neurosurgery Grand Rounds]

      Lazaridis C

    • SAH: critical care and monitoring.
      [Medicine Grand Rounds]

      Lazaridis C

    NINDS and ALS Association
    Workshop: Advances in Disease Modeling for ALS and FTD in San Diego, Calif. (2010)

    • Wing phenotypes produced by misexpression of an ALS-associated TDP-43 mutation include supernumerary veins: A possible clue to signaling pathways.

      Ambegaokar SS, Yusuff T, Choksi DK, Kayed R, Jackson GR

    Rice University and the Texas Medical Center
    Bioscience Research Collaborative in Houston, Texas (2010)

    • Real-time fMRI can decode visual mental imagery during a motion coherence task.

      Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

    Rush University
    CHAP Investigator Meeting in Chicago, Ill. (2010)

    • Genome-wide association scans for cognitive decline.
      [Oral Presentation]

      Shulman JM

    Washington Hospital Center (Georgetown and George Washington Universities)
    Washington, DC (2010)

    • Critical care aspects in the management of aSAH.
      [Critical Care Grand Rounds]

      Lazaridis C

    World Federation of Neurology (WFN)
    XVIII World Congress on Parkinson's Disease and Related Disorders in Miami Beach, Fla. (Dec. 13-16, 2009)

    • Rasagiline provides symptomatic beneflt in early Parkinson's disease (PD).

      Jankovic J, ADAGIO Investigators

    • Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD).

      Marks Jr W, Bartus R, Siffert J, Starr P, Ostrem J, Stacy M, et al.

    • Treatment of dysautonomia associated with Parkinson's disease.

      Mostile G, Jankovic J

    • Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?

      Sarwar A, Lai EC

    American Epilepsy Society (AES)
    63rd Annual Meeting in Boston, Mass. (Dec. 4-8, 2009)

    • Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.

      Bertaso F, Zhang X, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

    • Everyday verbal memory and pediatric epilepsy.

      Chapieski M, Evankovich K, Hiscock M, Collins R

    • High frequency EEG activity associated with ictal events in the TTX model of infantile spasms.

      Frost JD, Lee CL, Hrachovy RA, Swann JW

    • Long QT mouse model links the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.

      Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

    • Characteristics of psychogenic nonepileptic events among veterans with posttraumatic stress disorder: An association of semiology with the nature of trauma.

      Izadyar S, Chen DK

    • Epilepsy and neurocysticercosis in Houston, Texas.

      Kung D, Serpa-Alvarez J, Kass J, Friedman D

    • A burst suppression pattern at termination of secondarily generalized seizures.

      Maheshwari A, Cash SS

    Southern Medical Association (SMA)
    Annual Scientific Assembly in Nashville, Tenn. (Dec. 3-5, 2009)

    • Urinoma - A rare complication of prostatic carcinoma.

      Negi S, Anand A, Spannuth C

    Neurocritical Care Society (NCS)
    7th Annual Meeting in New Orleans, La. (Nov. 11-14, 2009)

    • Ventilator associated pneumonia in neurosurgical patients; results of a one year prospective observational study.

      Chalela JA, Ramos L, Anderson K, Hays A, Lazaridis C, Gay S, et al.

    • Clevidipine rapidly and safely reduces blood pressure in patients with acute intracerebral hemorrhage: interim results of the ACCELERATE trial - first clinical experience in ICH.
      [Platform Presentation]

      Graffagnino C, Bergese S, Love J, Schneider D, Lazaridis C, Lapointe M, et al.

    • Single brain death examination with confirmatory cerebral blood flow testing as an alternative to the standard dual brain death examination.

      Rao CV, Rehman M, Barber A, Sommerfield S, Patel A, Rai V, et al.

    Baylor College of Medicine (BCM)
    Current Neurology 2009 in Houston, Texas (Oct. 31 - Nov. 1, 2009)

    Society for Neuroscience (SFN)
    39th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2009)

    • TRPC1 is essential for glioma proliferation: A role for store-operated calcium entry.

      Bomben VC, Sontheimer H

    • MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.

      Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

    • MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.

      Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

    • Internally mediated developmental desynchronization of neocortical network activity.

      Golshani P, Goncalves JT, Khoshkhoo S, Mostany R, Smirnakis S, Portera-Cailliau C

    • Functional correlation of brain loci during cognitive tasks in multiple sclerosis.

      Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, et al.

    • Non-convulsive seizure phenotypes and dementia in mice and humans.

      Noebels JL

    • AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD): Efficacy and safety results from a controlled Phase 2 clinical trial.

      Siffert J, Marks Jr WJ, Starr PA, Stacey MA, Boulis NM, Vitek JL, et al.

    • Plasticity of hippocampo-cortical network connectivity induced by midline thalamic (n. Reuniens) stimulation in the rat.

      Viana Di Prisco G, Albo Z, Vertes RP

    • Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.

      Zhang X, Bertaso F, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

    American Neurological Association (ANA)
    134th Annual Meeting in Baltimore, Md. (Oct. 11-14, 2009)

    European Society of Intensive Care Medicine (ESICM)
    22nd Annual Congress in Vienna, Austria (Oct. 11-14, 2009)

    • Refractory status epilepticus: approach and management in a neurological intensive care unit.

      Hernandez OH, Suarez JI

    Optical Society of America (OSA)
    Annual Vision Meeting in Seattle, Wash. (Sept. 24, 2009)

    • Neural repair at the systems level: Lessons from the visual system.
      [Platform Presentation]

      Smirnakis SM

    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009)

    US Department of Defense
    Military Health Research Forum 2009 in Kansas City, Mo. (Aug. 31 - Sept. 3, 2009)

    VA Mental Health
    3rd Annual Conference in Washington, DC (July 21-23, 2009)

    • Clinical depression, anxiety, and PTSD as risk factors for morbidity following coronary artery bypass grafting surgery.

      Dao T, Nguyen Q, Chu D, Anderson T, Springer J, Collins R, et al.

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    20th International Nursing Research Congress in Vancouver, Canada (July 13-17, 2009)

    • The Self-management TO Prevent (STOP) Stroke Tool: A final alpha testing.

      Anderson J, Willson P

    2009 International Conference on Alzheimer's Disease (ICAD)
    Vienna, Austria (July 11-16, 2009)

    28th International Epilepsy Congress (IEC)
    Budapest, Hungary (June 29 - July 2, 2009)

    • Human KvLQT1 mutations in mice link the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.

      Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

    • Impact of maternal anxiety and age of child on restrictions in childhood activities.

      Schutlz RJ, Chapieski ML, Evankovich KD, Wilfong AA, Collins RL

    • Summary of the U.S. National Institute of Neurological Disorders and Stroke (NINDS) Workshop on SUDEP.

      So EL, Hirsch JL, Donner JE, Noebels JL, Jacobs PM, Buchhalter RJ

    University of Texas School of Public Health
    Alzheimers and Dementia Research Symposium in Houston, Texas (June 17, 2009)

    Movement Disorder Society (MDS)
    13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France (June 7-11, 2009)

    American College of Sports Medicine (ACSM)
    56th Annual Meeting in Seattle, Wash. (May 27-30, 2009)

    • Diagnosis of left ventricular hypertrophy by precordial vs. limb lead criteria in the analysis of ECGs over time in young athlete.

      Ananaba I, Damani R, West JJ, Higgins JP

    • Prevalence of LVH in athletes classified by race and gender.

      Damani R, Ananaba I, West JJ, Higgins JP

    Consortium of Multiple Sclerosis Centers (CMSC)
    23rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)

    European Stroke Conference (ESC)
    18th Annual Meeting in Stokholm, Sweden (May 26-29, 2009)

    • Platelet inhibition may explain results with abciximab in the treatment of acute ischemic stroke.

      Mandava P, Anderson J, Dalmeida W, Kent TA

    • A method to generate a control population for acute ischemic stroke trials: Validation with NINDS and application to a phase 1 treatment series.

      Mandava P, Kent TA

    Association for Research in Vision and Ophthalmology (ARVO)
    2009 Annual Meeting in Fort Lauderdale, Fla. (May 3-7, 2009)

    • Outcome of sequential glaucoma implants in refractory glaucoma.

      Anand A, Tello C, Sidoti PA, Ritch R, Liebmann JM

    American Academy of Neurology (AAN)
    61st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)

    American College of Cardiology (ACC)
    58th Annual Scientific Session in Orlando, Fla. (March 29-31, 2009)

    • Rates of abnormal screening electrocardiograms differ greatly between U.S. collegiate cohorts.

      West JJ, Higgins JP, McPherson DD, Mistry DJ, MacKnight JM, Saliba EN, et al.

    Medical University of South Carolina
    Integrated Stroke and Cerebrovascular Conference in Charleston, S.C. (March 12-14, 2009)

    • Neurocritical care for ischemic stroke.

      Lazaridis C

    • Overview of SAH 2009.

      Lazaridis C

    American Clinical Neurophysiology Society (ACNS)
    2009 Annual Meeting in Lake Buena Vista, Fla. (March 4-8, 2009)

    • Aggravation of seizures in two adolescent patients with epilepsy.

      Goldsmith IL

    Texas Scottish Rite Hospital for Children
    31st Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 19-20, 2009)

    • Anesthesiologist with muscle cramps.

      Ansari S, Smyth S, Harati Y

    • A tale of two diseases.

      Kung D, Harati Y

    • Myasthenia mimics.

      Nord K, Mosier D

    • Muscular dystrophy with subacute onset.

      Phan CL, Biliciler S, Harati Y

    • Another patient with burning feet.

      Smyth S, Harati Y

    • A case of a painful leg.

      Vullaganti M, Harati Y

    American Stroke Association
    2009 International Stroke Conference in San Diego, Calif. (Feb. 17-20, 2009)

    • Hyperglycemia is associated with edema progression in acute intracerebral hemorrhage.

      Ezzeddine MA, Tariq N, Vazquez G, Cordina SM, Georgiadis AL, Qureshi AI, et al.

    • Prevalence of asymptomatic intracranial atherosclerosis in a multi-ethnic population.

      Georgiadis AL, Suri MFK, Qureshi AI

    • Timing of complications following intracranial angioplasty and/or stent placement. Implications for post-procedural monitoring.

      Georgiadis AL, Tariq N, Memon MZ, Taqui AM, Qureshi AI

    • Occurrence and predictors of futile recanalization following intra-arterial thrombolysis among patients with acute ischemic stroke.
      [Previously Presented]

      Hussein HM, Georgiadis AL, Vazquez G, Qureshi AI

    • VWF pathway: A new animal model of lacunar stroke.

      Kent TA, Fabian RH, Dalmeida W, Ruidong J, Dong JF

    • Restoring balance: A method to adjust for randomization imbalances in stroke clinical trials.

      Mandava P, Kent TA

    • Safety and efficacy of anticoagulation with bivalirudin in neuro-endovascular procedures.

      Memon MZ, Georgiadis AL, Vazquez G, Shah QA, Suri MFK, Qureshi AI

    • A multicenter analysis of "time to microcatheter" for endovascular therapy in acute ischemic stroke.

      Miley JT, Memon MZ, Hussein HM, Valenta DA, Suri MFK, Vazquez G, et al.

    • Foundations for a successful start: lessons learned from site initiation in the antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.

      Novitzke JM, Qureshi AI, the ATACH Investigators

    • Effect of systolic blood pressure treatment on perihematomal edema. Results from the antihypertensive treatment of acute cerebral hemorrhage (ATACH) study.

      Qureshi AI, Palesch YY, the ATACH Investigators

    • Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.

      Suarez JI, for the ALISAH Investigators

    International Neuropsychological Society (INS)
    37th Annual Meeting in Atlanta, Ga. (Feb. 11-14, 2009)

    American Society of Neuroimaging (ASN)
    32nd Annual Meeting in Orlando, Fla. (Jan. 22-25, 2009)

    • Occurrence and predictors of futile recanalization following intra-arterial thrombolysis among patients with acute ischemic stroke.

      Hussein HM, Georgiadis AL, Vazquez G, Miley JT, Memon MZ, Qureshi AI

    VA's Health Services Research & Development Service (HSR&D)
    Quality Enhancement Research Initiative (QUERI) National Meeting in Phoenix, Ariz. (Dec. 10-12, 2008)

    • Implementation of patient self-management programs among veterans in VA.

      Damush, Anderson J, Bosworth H

    American Epilepsy Society (AES)
    62nd Annual Meeting in Seattle, Wash. (Dec. 5-9, 2008)

    American Academy of Physical Medicine and Rehabilitation (AAPM&R)
    2008 Annual Assembly in San Diego, Calif. (Nov. 20-23, 2008)

    Society for Neuroscience (SFN)
    38th Annual Meeting in Washington, DC (Nov. 15-19, 2008)

    • TRPC1 and store operated calcium entry in human malignant gliomas.

      Bomben VC, Sontheimer H

    • Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

      Glasscock E, Yoo JW, Noebels JL

    • Alzheimer's disease as descent into randomness: Evidence from category fluency testing.

      Lerner AJ, Albo Z, Messer J, Singh T, Woyczynski W

    National Multiple Sclerosis Society (NMSS)
    Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008)

    International Symposium on ALS/MND
    19th Annual Meeting in Birmingham, UK (Nov. 3-5, 2008)

    Society of Vascular and Interventional Neurology (SVIN)
    2nd Annual Meeting in Miami, Fla. (Oct. 24-26, 2008)

    • Endovascular stent supported coil and onyx glue embolization of carotico-cavernous fistulae.

      Rao CV, Braun C, Jones M, Xavier A

    • Stent alone treatment for anterior circulation cerebral aneurysms.

      Rao CV, Kuruvilla A, Jones M, Lee A, Tiwari A, Xavier A

    • Stent without concomitant coil embolization for dissecting external carotid aneurysms.

      Rao CV, Lee A, Jones M, Tiwari A, Kansara A, Guthikonda M, et al.

    Neurocritical Care Society (NCS)
    6th Annual Meeting in Miami, Fla. (Oct. 23-25, 2008)

    • General trauma and ATLS.
      [Neurocritical Care: Certification Review Course]

      Lazaridis C

    • A case of methemoglobinemia after awake fiberoptic intubation following anterior cervical discectomy with fusion (ACDF).

      Rao CV, Varelas P, Wellwood J, Seyfried D, Abdelhak T

    6th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders
    Dresden, Germany (Oct. 16-19, 2008)

    American Neurological Association (ANA)
    133rd Annual Meeting in Salt Lake City, Utah (Sept. 21-24, 2008)

    • Coagulopathy is an independent predictor of inhospital mortality in patients with acute subdural hematoma.

      Bershad EM, Farhadi S, Suri MF, Feen ES, Hernandez OH, Selman WR, et al.

    • Altered age of onset in Alzheimer's disease with diabetes mellitus.

      Shirani P, Salamone AR, Strutt AM, Schulz PE

    • Is frontal dysfunction associated with dysarthria in patients with Amyotrophic Lateral Sclerosis (ALS)?

      Sterling LE, Salamone AR, Mosnik DM, Appel SH, Strutt AM, Schulz PE

    • Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.

      Xie W, Zhu W, Pan T, Jankovic J, Le W

    World Stroke Organization (WSO)
    10th International Symposium on Thrombolysis and Acute Stroke Therapy in Budapest, Hungary (Sept. 21-23, 2008)

    • A systematic analysis of intravenous rt-PA vs. endovascular therapy with respect to therapeutic time window in acute ischemic stroke.

      Mandava P, Kent TA

    • Low-dose intravenous abciximab and heparin for large vessel acute ischemic stroke: Comparison with natural history models.

      Mandava P, Kent TA

    World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
    Montreal, Quebec, Canada (Sept. 17-20, 2008)

    • Menstrual cycle and menopause in patients with multiple sclerosis. How do these affect the symptoms of disease?

      Avila M, Suarez GA, Brandt D, Ramirez J, Hutton GJ, Rivera VM

    • Natalizumab use in a large multiple sclerosis center: Ascertaining the therapeutic benefit and the causes for treatment discontinuation.

      Batra N, Ramanathan M, Hojnacki D, Miller C, Umhauer M, Stosic M, et al.

    • Longitudinal individualized analysis of computer-based cognitive rehabilitation in multiple sclerosis.

      Chaliman RT, Perez FI, Suarez GA, Rivera VM, Hutton GJ

    • 3T predicts better clinical and demographic outcomes in patients with multiple sclerosis than 1.5T. A preliminary case-control study.

      Di Perri C, Dwyer M, Cox JL, Hashmi K, Wack D, Hussein S, et al.

    • Lesion characteristics at 1.5 and 3 Tesla in multiple sclerosis patients and healthy controls: A morphological and topological quantitative comparison study.

      Di Perri C, Dwyer M, Wack D, Cox JL, Hashmi K, Saluste E, et al.

    • ApoE ε4 positive multiple sclerosis patients develop more gray matter and whole brain atrophy: A 4-year longitudinal study using the 15-year disease onset model.

      Horakova D, Kyr M, Havrdova E, Dolezal O, Seidl Z, Vaneckova M, et al.

    • Can magnetization transfer data from different magnetic resonance imaging scanner/sequence/pulse types be standardized? An application of correction factor function method.

      Kelemen A, Dwyer MG, Hussein S, Stosic M, Liang Y, Zivadinov R

    • Conventional and non-conventional quantitative magnetic resonance imaging outcomes differ when comparing multiple definitions of benign multiple sclerosis.

      Passanese J, Kelemen A, Weinstock-Guttman B, Teter B, Mihai C, Hojnacki D, et al.

    • Protective clinical, demographic and conventional and non-conventional magnetic resonance imaging predictors of benign multiple sclerosis: A large cohort study.

      Passanese J, Kelemen A, Weinstock-Guttman B, Teter B, Mihai C, Hojnacki D, et al.

    • RENEW study update XVIII: Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis.

      Rivera V, AL-Sabbagh A, Bennett R, Coyle P, Elias S, Mikol D, et al.

    • Does multiple sclerosis become an ischemic disease over time? A 3-year follow-up study of patients positive for the presence of anti-phospholipid antibodies.

      Stosic M, Weinstock-Guttman B, Vutla B, Ambrus J, Ramanathan M, Munschauer F, et al.

    • Magnetic resonance imaging findings in patients with clinically isolated syndrome suggestive of multiple sclerosis.

      Suarez GA, Avila M, Brandt D, Rivera VM, Hutton GJ

    Mechanisms of Epilepsy and Neuronal Synchronization
    Gordon Research Conference in Waterville, Maine (Aug. 3-8, 2008)

    • Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

      Glasscock E, Yoo JW, Noebels JL

    2008 International Conference on Alzheimer's Disease (ICAD)
    Chicago, Ill. (July 26-31, 2008)

    International Society for Research on Aggression (ISRA)
    18th World Meeting in Budapest, Hungary (July 8-13, 2008)

    • Towards a developmental model of impulsive aggression: Alexithymia as the confluence of neurobiological and psychological determinants.

      Teten, A, Kent TA

    Movement Disorder Society (MDS)
    12th International Congress of Parkinson's Disease and Movement Disorders in Chicago, Ill. (June 22-26, 2008)

    Canadian Neurological Sciences Federation (CNSF)
    43rd Annual Congress in Victoria, British Columbia, Canada (June 17-20, 2008)

    • A novel method for detecting cardiac dysfunction in Duchenne muscular dystrophy.

      Phan C, Poppe C, Smallhorn J, Dyck J, Patton D, Harder J, et al.

    Jamaican League Against Epilepsy (JLAE)
    1st North American Regional Caribbean Congress on Epilepsy in Montego Bay, Jamaica (May 30-31, 2008)

    • Sensitivity and specificity of video alone versus electroencephalography alone for the diagnosis of partial seizures.

      Chen DK, Graber KD, Anderson CT, Fisher RS

    Consortium of Multiple Sclerosis Centers (CMSC)
    22nd Annual Meeting in Denver, Colo. (May 28-31, 2008)

    European Stroke Conference (ESC)
    17th Annual Meeting in Nice, France (May 13-16, 2008)

    • Improved prediction of treatment success in stroke based on pooled control arms.

      Mandava P, Kent TA

    American Academy of Neurology (AAN)
    60th Annual Meeting in Chicago, Ill. (April 12-19, 2008)

    Genetics Society of America (GSA)
    49th Annual Drosophila Research Conference in San Diego, Calif. (April 2-6, 2008)

    • Drosophila EHBP-1 is required for Notch signaling during external sensory organ development.
      [*equal contribution]

      Yamamoto S*, Giagtzoglou N*, Andrews HK, Wang H, Schulze KL, Bellen HJ

    American Society for Neurochemistry (ASN)
    39th Annual Meeting in San Antonio, Texas (March 1-5, 2008)

    • Inhibition of transient receptor potential canonical channels arrests cytokinesis in human malignant glioma cells.

      Bomben VC, Sontheimer H

    American Stroke Association
    2008 International Stroke Conference in New Orleans, La. (Feb. 20-22, 2008)

    • The self-management to prevent stroke clinic: teaching, translational research and technology.

      Anderson JA, Willson P

    • Natural history of asymptomatic restenosis following endovascular treatment of symptomatic intracranial stenosis does not support retreatment.
      [Platform Presentation]

      Hussein HM, Abdelmoula M, Qureshi AI

    • Platelet aggregation unit inhibition to guide abciximab therapy in acute ischemic stroke: preliminary results.

      Mandava P, Anderson J, Thiagarajan P, Kent TA

    • A method to predict stroke trial success based on pooled control arms.

      Mandava P, Kent TA

    • Rates and predictors of clinical and radiological outcomes in acute ischemic stroke patients without angiographic occlusion. A multicenter review.

      Shah QA, Suri MFK, Hussein HM, Mohammad YM, Qureshi AI

    • Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.

      Suarez JI, for the ALISAH Investigators

    • Antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.

      The ATACH Investigators

    Texas Scottish Rite Hospital for Children
    30th Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 20-22, 2008)

    • A case of FSH?

      Ansari S, Biliciler S, Mytu S, Harati Y

    • A case of nemaline myopathy masquerading as fascioscapulohumeral dystrophy.

      Ansari S, Harati Y

    • A case of Ehlers-Danlos.

      Biliciler S, Smyth S, Harati Y

    • Progressive ascending weakness in an acquired immunodeficiency syndrome patient.

      Kung D, Kuo S-H, Kwan J

    • Peau d'Orange skin changes and muscle weakness.

      Kuo S-H, Kung D, Kwan JY

    • Diffuse painful muscle spasms.

      Satija P, Clark G, Killian J

    • Why does my patient have camptocormia?

      Smyth S, Biliciler S, Kwan J, Harati Y

    American Stroke Association
    International Stroke Conference, 2008 State-of-the-Art Stroke Nursing Symposium in New Orleans, La. (Feb. 19, 2008)

    • The Self-management TO Prevent (STOP) Stroke Clinic: Teaching, translational research and technology.

      Anderson J, Willson PC, Kent TA

    Society of Critical Care Medicine (SCCM)
    37th Critical Care Congress in Honolulu, Hawaii (Feb. 2-6, 2008)

    • Mechanical ventilation in status epilepticus.

      Lazaridis C, Ziai W, Venkatraman A, Kim G, Geocadin R

    Howard Hughes Medical Institure (HHMI)
    Development Meeting in Bethesda, Md. (2008)

    • dEHBP1 is a novel regulator of Notch signalling.

      Giagtzoglou N, Yamamoto S, Wang H, Andrews HK, Schulze KL, Bellen HJ

    Medical University of South Carolina
    Charleston, S.C. (2008)

    • Cerebral autoregulation: can we and should we monitor it?
      [Neuroscience Grand Rounds]

      Lazaridis C

    International Symposium on ALS/MND
    18th Annual Meeting in Toronto, Canada (Dec. 1-3, 2007)

    American Epilepsy Society (AES)
    61st Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 4, 2007)

    • Growth curve analysis of changes in spatial and verbal learning characteristics after anterior temporal lobectomy.

      Dulay MF, Levin HS, Mizrahi EM, York MK, Li X, Goldsmith IL, et al.

    • Masking epilepsy by combining two epilepsy mutations.

      Glasscock E, Qian J, Yoo JW, Noebels JL

    • Genomic research in the era of identifiable genetic information.

      Goldman AM, McGuire AL, Hilsenbeck SG, Noebels JL

    • Persistent focal neocortical abnormalities in the TTX model of infantile spasms.

      Lee CL, Antalffy B, Frost JD Jr, Hrachovy RA, Swann JW

    • Varied roles of BK-type potassium channels in the regulation of neuronal excitability: Which are important for epilepsy?

      Sanchez RM, Storm JF, Richerson GB, Barth A, Noebels JL

    Michael E. DeBakey Veterans Affairs Medical Center
    Advanced Practice Nursing Conference on the Management of Chronic Disease in Houston, Texas (November 2007)

    • Stroke secondary prevention: an exemplar for the chronic care model.

      Anderson J

    National Academy of Neuropsychology (NAN)
    27th Annual Meeting in Scottsdale, Ariz. (Nov. 14-18, 2007)

    Society for Neuroscience (SFN)
    37th Annual Meeting in San Diego, Calif. (Nov. 3-7, 2007)

    • Interactions between brain tumors and endothelial cells.

      Bomben VC, Olsen ML, Sontheimer H

    • The role of zinc-deficient superoxide dismutase in motor neuron apoptosis.

      Sahawneh MA, Ricart KC, Bomben VC, Estevez AG

    Mexican Academy of Neurology
    31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007)

    Neurocritical Care Society (NCS)
    7th Annual Meeting in Las Vegas, Nev. (Oct. 31 - Nov. 3, 2007)

    • Intra-aortic balloon counterpulsation in the setting of aneurysmal subarachnoid hemorrhage, cerebral vasospasm, and cardiac stunning.

      Lazaridis C, Nyquist P

    • Ventilator associated pneumonia in status epilepticus.

      Lazaridis C, Ziai W, Geocadin R

    • Endotracheal intubation for management of adult status epilepticus.

      Ziai W, Lazaridis C, Geocadin R

    American College of Physicians (ACP)
    Tennessee Chapter Scientific Meeting in Chattanoogan, Tenn. (Oct. 12-13, 2007)

    • Doctor - A case of benign thyroid cyst causing reversible Horner's syndrome.

      Negi S, Anand A

    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007)

    American Neurological Association (ANA)
    132nd Annual Meeting in Washington, DC (Oct. 7-10, 2007)

    Colombian Academy of Neurology
    VIII Meeting in Cali, Colombia (Aug. 16-19, 2007)

    American Nurses Association (ANA)
    Symposium on Nursing Care in Life, Death and Disaster in Atlanta, Ga. (June 2007)

    • Real world response to Katrina.

      Lockhart MC, Anderson JA

    2nd International Frontotemporal Dementia in ALS Research Conference
    London, Ontario Canada (June 10-13, 2007)

    Alzheimer's Association International Conference (AAIC)
    Washington, DC (June 9-12, 2007)

    Federation of Clinical Immunology Societies (FOCIS)
    7th Annual Meeting in San Diego, Calif. (June 7-11, 2007)

    • HIV-1 infectivity inhibited by binding of the green tea catechin, epigallocatechin gallate, to CD4.

      Nance C, Siwack E, Ram A, Willis V, Westerfield S, Shearer W

    Movement Disorder Society (MDS)
    11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)

    Consortium of Multiple Sclerosis Centers (CMSC)
    21st Annual Meeting in Washington, DC (May 30 - June 2, 2007)

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2007, 23rd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Osaka, Japan (May 20-24, 2007)

    • The concept of "functional uncoupling" as a cause of vascular dysfunction following neonatal hypoxic/ischemic injury.

      Fabian RH, Perez-Polo JR, Kent TA

    American Academy of Neurology (AAN)
    59th Annual Meeting in Boston, Mass. (April 28 - May 5, 2007)

    • Malignant Tourette syndrome.

      Cheung MC, Shahed J, Jankovic J

    • Results of the Avonex Combination Trial (ACT).

      Cohen J, Calabresi P, Eickenhorst T, Edwards K, Felton W, Fisher E, et al.

    • Angiographic findings in patients with spontaneous intracerebral hemorrhage.

      Cordina SM, Ezzeddine M, El-Gengaihy AE, Georgiadis A, Kirmani J, Qureshi A

    • Three parkin mutations in a family with Parkinson's disease.

      Deng H, Le W, Shahed J, Jankovic J

    • What American Heart Association guideline criteria to use for acute hypertension treatment in intracerebral hemorrhage?

      Divani AA, Nasar MS, Suri MFK, Hussein HM, Rodriguez GJ, Ezzeddine MA, et al.

    • Dimebon improves cognition, function, and behavior in patients with mild- moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled study.

      Doody R, Gavrilova S, Sano M, Thomas R, Aisen P, Seely L, et al.

    • Acute formation of leptomeningeal collaterals in proximal middle cerebral artery occlusion.

      El-Gengaihy A, Hussein HM, Liebeskind DS, Divani AA, Ezzeddine MA, Qureshi AI

    • Use of aspirin is not associated with higher rates of intracranial hemorrhage in patients treated with endovascular procedures for acute ischemic stroke.

      Georgiadis AL, Hussein HM, Baybutt TR, Suri MFK, Qureshi AI

    • Poor interobserver agreement for distinguishing between symptomatic and asymptomatic intracerebral hemorrhage following thrombolysis among vascular neurologists.

      Georgiadis AL, Shah QA, Suri MFK, Rodriguez GJ, Ezzeddine MA, Qureshi AI

    • Reliability of self assessment of cardiovascular risk.

      Hussein H, Zhou J, Stalcup P, Harris-Lane P, Abdulmoula M, Qureshi A

    • Subacute recanalization and re-occlusion following intra-arterial thrombolysis in patients with ischemic stroke.

      Hussein HM, Janjua N, Harris-Lane P, Divani AA, Georgiadis AL, Qureshi AI

    • Autopsy-proven Huntington disease with 29 trinucleotide repeats.
      [Previously Presented]

      Kenney C, Powell S, Jankovic J

    • Autophagy induction and its neuroprotection on neurotoxin-induced cell injury relevant to Parkinson's disease.

      Pan T, Li X, Zhu W, Xie W, Jankovic J, Le W

    • A concurrent comparison of primary angioplasty and primary stent placement in high-risk patients with symptomatic intracranial stenosis.

      Qureshi A, El-Gengaihy A, Hussein H, Suri MF, Harris-Lane P, Al Kawi A, et al.

    • Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study.

      Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, et al.

    • Intra-arterial nicardipine for acute ischemic stroke.
      [Previously Presented]

      Shah QA, Georgiadis AL, Suri MFK, Al-Kawi A, Qureshi AI

    • Motor overflow, contralateral dystonia and mirror movements in focal hand dystonia.

      Sitburana O, Wu LJC, Sheffield KJ, Davidson A, Jankovic J

    • External validation of a scheme to identify persons for asymptomatic carotid artery stenosis screening.

      Suri MF, Qureshi A, Hussein H, Berezina T, Wright E, Divani A

    • Safety and tolerability of 600 mg clopidogrel bolus in patients with acute cerebral ischemia.

      Suri MFK, Hussein HM, Patel A, Rodriguez GJ, Ibrahim MS, Ezzeddine MA, et al.

    • Head injury with amnesia and risk of multiple system atrophy (MSA).

      Tanner C, Kukrull W, Shults C, Comyns K, Bhudhikanok G, May S, et al.

    • Novel brain permeable iron chelators prevent lactacystin induced ubiquitn-proteasome inhibition and degeneration of nigrostrialtal dopamine neurons.

      Zhu W, Pan T, Xie W, Xu P, Zheng H, Fridkin M, et al.

    • Proteasome inhibition in substantial nigra induces sustained dopamine cells degeneration.

      Zhu W, Pan T, Zhang X, Xie W, Jankovic J, Le W

    Society of Vascular and Interventional Neurology (SVIN)
    Inaugural Meeting in Boston, Mass. (April 27-28, 2007)

    • Endovascular treatment of dural venous thrombosis.

      Qureshi AI, Taylor RA, Georgiadis AL, Suri MFK, Shah QA, Rodriguez GJ, et al.

    8th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
    Salzburg, Austria (March 14-18, 2007)

    Genetics Society of America (GSA)
    48th Annual Drosophila Research Conference in Philadelphia, Penn. (March 7-11, 2007)

    • Identification of novel genes involved in external sensory organ formation.

      Giagtzoglou N, Andrews H, Schulze KL, Yamamoto S, Bellen H

    Texas Scottish Rite Hospital for Children
    29th Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 22-23, 2007)

    • Unusual cause of rhabdomyolysis.

      Biliciler S, Harati Y, Kwan J, Lindsay A

    • Progressive muscle weakness and joint contractures.

      Kwan J, Harati Y

    • Recurrent compartment syndrome.

      Lindsay A, Harati Y, Kwan J, Biliciler S

    North American Neuro-Ophthalmology Society (NANOS)
    33rd Annual Meeting in Snowbird, Utah (Feb. 10-15, 2007)

    International Neuropsychological Society (INS)
    35th Annual Meeting in Portland, Ore. (Feb. 7-10, 2007)

    • Development of child and parent report measures of subjective memory.

      Chapieski L, Evankovich K, Collins R, Hiscock M

    American Stroke Association
    2007 International Stroke Conference in San Francisco, Calif. (Feb. 7-9, 2007)

    • Are patients recruited in clinical trials appropriately representative of the patients treated with endovascular treatment for acute ischemic stroke?

      Alkawi A, Hussein HM, Janjua N, Patel AS, Suri MFK, Harris-Lane P, et al.

    • Intra-arterial thrombolysis for patients with ischemic stroke aged 80 years or greater: Pooled analysis from four prospective studies.

      Alkawi A, Janjua N, Hussein HM, Patel AS, Baybutt T, Qureshi AI

    • Comparison of patients with intracerebral hemorrhage treated within and outside clinical trials: A report of the antihypertensive treatment of acute cerebral hemorrhage investigators.

      ATACH study Investigators

    • Abrnomal platelet function is associated with hematoma growth in primary intracerebral hemorrhage.

      Ezzeddine MA, Malik AK, Hussein HM, Jacob M, Suri MFK, Kirmani JF, et al.

    • Use of anti-platelet medications is not associated with higher rates of intracranial hemorrhage in patients treated with endovascular procedures for acute ischemic stroke.

      Georgiadis AL, Hussein HM, Baybutt TR, Suri MFK, Alkawi A, Qureshi AI

    • Current statin use is associated with higher recanalization rates among patients treated with endovascular procedures for acute ischemic stroke.
      [Previously Presented]

      Georgiadis AL, Hussein HM, Wright IV EJ, Suri MFK, Alkawi A, Qureshi AI

    • The quality of adverse event reporting in drug-related hemorrhagic stroke trials from the stroke trials registry.

      Hussein HM, Baybutt TR, Zhou J, Divani AA, Qureshi AI

    • Reliability of self assessment of cardiovascular risk.

      Hussein HM, Zhou J, Stalcup P, Harris-Lane P, Abdelmoula M, Qureshi AI

    • Factors associated with good outcome following intra-arterial therapy for acute ischemic stroke: a severity-adjusted systematic review.

      Mandava P, Kent TA

    • Age does not increase risk of symptomatic intracranial hemorrhage after thrombolysis for acute ischemic stroke.

      McWilliams-Dunnigan LF, Suarez JI, Kirchner HL, Lynch G, Sundararajan S, Sunshine J, et al.

    • A concurrent comparison of primary angioplasty and primary stent placement in high-risk patients with symptomatic intracranial stenosis.

      Qureshi AI, El-Gengaihy A, Hussein HM, Suri MFK, Harris-Lane P, Alkawi A, et al.

    • Intra-arterial nicardipine for acute ischemic stroke.

      Shah QA, Georgiadis AL, Suri MFK, Al-Kawi A, Qureshi AI

    • Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.

      Suarez JI, Murphy C, Feen ES, Bershad E, for the ALISAH Investigators

    • External validation of a scheme to identify persons for asymptomatic carotid artery stenosis screening.

      Suri MFK, Hussein HM, Patel A, Berezina T, Wright E, Divani AA, et al.

    American Society of Neuroimaging (ASN)
    30th Annual Meeting in Miami, Fla. (Jan. 18-21, 2007)

    • Current statin use is associated with higher recanalization rates among patients treated with endovascular procedures for acute ischemic stroke.

      Georgiadis AL, Hussein HM, Wright IV EJ, Suri MFK, Alkawi A, Qureshi AI

    American Epilepsy Society (AES)
    60th Annual Meeting in San Diego, Calif. (Dec. 1-5, 2006)

    • Expression profile of voltage-gated sodium channel genes in two knockout mouse models exhibiting spontaneous seizures.

      Ernst SJ, Isom L, Burgess DL, Noebels JL

    • Development of a transgenic mouse model of spike-wave epilepsy by overexpression of α1G T-type calcium channels.

      Ernst WL, Yoo JW, Burgess DL, Noebels JL

    • The prevalence of inter-ictal cardiac arrhythmias and LQT gene variants in patients with idiopathic epilepsy.

      Goldman AM, Burgess DL, Gibbs RA, Chapman KE, Wilfong AA, Hrachovy RA, et al.

    • Sodium amobarbital dosing in patients with diffuse unilateral hemispheric abnormalities.

      Goldsmith IL, Verma A

    • Effects of vagus nerve stimulation on daytime sleepiness.

      Kawai M, Yoshor D, Goldsmith IL, Verma A

    • Neonatal blockade of cortical or hippocampal activity: A possible model of infantile spasms.

      Lee CL, Frost JD Jr, Swann JW, Hrachovy RA

    International Symposium on ALS/MND
    17th Annual Meeting in Yokohama, Japan (Nov. 30 - Dec. 2, 2006)

    Neurocritical Care Society (NCS)
    4th Annual Meeting in Baltimore, Md. (Nov. 4-5, 2006)

    • Coagulopathy is an independent predictor of in-hospital mortality in patients with acute subdural hematoma.

      Suarez JI, Feen ES, Suri MFK, Bershad E, Mirabelli J, Lynch G, et al.

    Mexican Academy of Neurology
    30th Annual Meeting in Merida, Yucatan, Mexico (Oct. 30 - Nov. 4, 2006)

    Movement Disorder Society (MDS)
    10th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)

    Society for Neuroscience (SFN)
    36th Annual Meetingin Atlanta, Ga. (Oct. 14-18, 2006)

    • Role of transient receptor potential canonical channels in glioma cell physiology.

      Bomben VC, Sontheimer H

    American Neurological Association (ANA)
    131st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)

    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    22nd Congress in Madrid, Spain (Sept. 27-30, 2006)

    • Menstrual disorders in multiple sclerosis patients receiving interferon-beta.

      Lotfi J, Zohrevand P, Heshmat A, Sahraian M, Parsi H, Bagheri M

    International Congress of Clinical Neurophysiology (ICCN)
    28th Meeting in Edinburgh, Scotland (Sept. 10-14, 2006)

    • The use of intraoperative transcranial motor evoked potential (TcMEPs) monitoring in the surgical management of cerebral aneurysms.

      Lopez JR, Chen DK, Cho SC, Chang S, Steinberg G

    5th International Conference on Frontotemporal Dementia
    San Francisco, Calif. (Sept. 6-8, 2006)

    International Society for Developmental Neuroscience (ISDN)
    16th Biennial Meeting in Banff, Canada (Aug. 24-28, 2006)

    • Functional uncoupling of endothelial nitric oxide and superoxide radical following neonatal hypoxia/ischemia.

      Fabian RH, Perez-Polo JR, Kent TA

    • Relation of blood oxygenation in the first hours of life and school age outcomes in "healthy" children born at very low birthweight.

      Smith KE, Keeney SE, Susabda A, Rassin DK, Kent TA, Fabian RH, et al.

    Mechanisms of Epilepsy and Neuronal Synchronization
    Gordon Research Conference in Waterville, Maine (Aug. 6-11, 2006)

    • Ion channel gene interactions in inherited epilepsy.

      Glasscock E, Yoo J, Noebels JL

    10th International Conference on Alzheimer's Disease and Related Disorders
    Madrid, Spain (July 15-20, 2006)

    World Federation of Neurology (WFN)
    11th International Congress on Neuromuscular Diseases in Istanbul, Turkey (July 2-7, 2006)

    12th International Congress on Infectious Diseases (ICID)
    Lisbon, Portugal (June 15-18, 2006)

    • Seroepidemiology of Crimean-Congo haemorrhagic fever among butchers and slaughters of the Isfahan province, Iran in 2005.

      Karimi I, Rostami M, Chinikar S, Ataei B, Darvishi M, Jalali N, et al.

    13th International Congress of Neurology and Clinical Electrophysiology
    Tehran, Iran (June 5-8, 2006)

    • The use of distal protection device in endovascular therapy of arterial occlusive diseases.
      [Platform Presentation]

      Divani AA, Hussein HM, Berezina T, Zhou J, Mahbobi R, Kirmani J, et al.

    • The impact of pre-existing heart failure on in-hospital outcomes among patients with ischemic stroke in the United States.
      [Platform Presentation]

      Divani AA, Qureshi AI, Hussein HM, Zhou J, Pullicino P

    Federation of Clinical Immunology Societies (FOCIS)
    6th Annual Meeting in San Francisco, Calif. (June 1-5, 2006)

    • HIV-1-GP120-induced T-cell responses attenuated by the green tea catechin, epigallocatechin gallate (EGCG).

      Nance C, Ram A, Paulson S, Shearer W

    European Neurological Society (ENS)
    16th Annual Meeting in Lausanne, Switzerland (May 27-31, 2006)

    • Multiple sclerosis in Iran: a demographic study of 5,000 patients.

      Lotfi J, Parsi H, Zohrevand P, Alikhani K, Sahraian M

    Russian Academy of Medical Sciences
    10th Annual Session of the Bakoulev Scientific Center for Cardiovascular Surgery, Russian Academy of Medical Sciences in Moscow, Russia (May 14-16, 2006)

    • Rationale for the use of distal cerebral protection devices in stenting of vertebral and internal carotid arteries.
      [Platform Presentation]

      Divani AA, Berezina TL, Hussein HM, Janjua N, Zaets SB, Mahboobi R, et al.

    • Pre-existing congestive heart failure among patients with ischemic stroke in the United States.
      [Platform Presentation]

      Divani AA, Zaets SB, Hussein HM, Zhou J, Pullicino PM, Qureshi AI

    • The impact of pre-hypertension on cardiovascular diseases.
      [Platform Presentation]

      Qureshi AI, Divani AA, Zaets SB, Suri FM, Hussein HM, Berezina TL, et al.

    American Academy of Neurology (AAN)
    Guidelines, Practice and Advocacy Open House in San Diego, Calif. (April 3, 2006)

    • Use of serum prolactin in diagnosing epileptic seizures.

      Chen DK, So YT, Fisher RS

    American Academy of Neurology (AAN)
    58th Annual Meeting in San Diego, Calif. (April 1-8, 2006)

    • Acute ischemic stroke without angiographic occlusion is not a benign entity.

      Alkawi A, Janjua NA, Hussein HM, Divani AA, Kirmani JF, Ezzeddine MA, et al.

    • An angiographic study of the anatomical variations of 224 middle cerebral arteries.

      Al-Kawi A, Shhadeh A, Janjua N, Kirmani JF, Georgiadis AL, Harris-Lane P, et al.

    • Predictors of long-term mortality in ischemic stroke patients requiring critical care.

      Broderick M, Suarez JI, Feen E, Suri MFK, Amina S, Mirabelli J, et al.

    • Rationale, design, and baseline data for the Avonex Combination Trial (ACT).

      Cohen J, Calabresi P, Edwards K, Eickenhorst T, Felton W, Fisher E, et al.

    • Prevalence of urinary incontinence in a large cohort of stroke survivors: Health and retirement survey 2002.

      Divani AA, Hussein HM, Jingying Z, Zaets SB, Berezina TL, Qureshi AI

    • Post-stroke sleep disturbances are frequent among stroke survivors: Results from health and retirement study survey 2002.

      Divani AA, Jingying Z, Hussein HM, Zaets SB, Berezina TL, Qureshi AI

    • Predicting progression of Alzheimer's disease.

      Doody R, Pavlik V, Massman P, Rountree S, Darby E, Chan W

    • Trends in incidence and outcome of grand mal status epilepticus in the United States.

      Georgiadis AL, Nasar A, Suri MFK, Ezzeddine MA, Kirmani JF, Hasein SA

    • Thrombolysis in acute ischemic stroke among pediatric patients lags behind adult cohorts.

      Janjua N, Nasar A, Suri MFK, Al-Kawi A, Georgiadis AL, Ezzeddine MA, et al.

    • Short-term and long-term safety of deep brain stimulation in the treatment of movement disorders.

      Kenney C, Simpson Jr RK, Hunter CB, Ondo WG, Almaguer M, Davidson A, et al.

    • Long term safety of deep brain stimulation for the treatment of Parkinson's disease.

      Kenney CJ, Vuong K, Hunter C, Almaguer M, Jankovic J

    • Can early nutrition be detrimental to critically ill cerebrovascular disease patients?

      Lynch G, Sawicki M, Cheruvu VK, Mirabelli J, Suarez JI

    • Nurrl deficiency predisposes to apoptosis induced by lactacystin in SH-SY5Y cells in vitro.

      Pan T, Xie W, Deng H, Zhao H, Jankovic J

    • Early and long-term outcomes with drug eluting stents in high-risk patients with symptomatic intracranial stenosis.

      Qureshi AI, Kirmani JF, Harris-Lane P, Divani AA, Alkawi A, Hussein HM, et al.

    • Bilateral GPI deep brain stimulation for Tourette syndrome.

      Shahed J, Poysky J, Kenney C, Simpson Jr RK, Jankovic J

    • Frontostriatal cognitive functioning 6 months following bilateral subthalamic nucleus deep brain stimulation.

      York MK, Jankovic J, Lai EC, Dulay M

    Genetics Society of America (GSA)
    47th Annual Drosophila Research Conference in Houston, Texas (March 29 - April 2, 2006)

    • The synergy between Senseless and proneural proteins is mediated by protein-protein interactions.

      Acar M, Jafar-Nejad H, Giagtzoglou N, Yallampalli S, David G, He Y, et al.

    • The role of importin13 in the synaptic connectivity of Drosophila photoreceptors.

      Giagtzoglou N, Hiesinger PR, Maier M, Zhou Y, Bellen H

    American Society for Neurochemistry (ASN)
    37th Annual Meeting in Portland, Ore. (March 11-15, 2006)

    • Transient receptor potential canonical channels in glioma cells.

      Bomben VC, Sontheimer H

    North American Neuro-Ophthalmology Society (NANOS)
    32nd Annual Meeting in Tucson, Ariz. (Feb. 25 - March 2, 2006)

    • The implication of glutamic acid decarboxylase autoantibodies in nystagmus: A case report.

      Pacheco VH, Selhorst JB, Chung SM

    American Society of Interventional and Therapeutic Neuroradiology (ASITN)
    2006 Annual Meetining in Orlando, Fla. (Feb. 18-20, 2006)

    • Computed tomography and stroke severity predict the time interval between symptom onset (TSO) and presentation.

      Georgiadis AL

    • Delayed angiographic recanalization and re-occlusion impacts on outcome in patients treated with thrombolytics for acute ischemic stroke.
      [Previously Presented]

      Janjua N, Nasar A, Harris-Lane P, Al-Kawi A, Georgiadis AL

    • Is post-stent angioplasty required during carotid angioplasty and stent placement?

      Kirmani JF, Janjua N, Al-Kawi A, Ibrahim MS, Georgiadis AL, Malik AK, et al.

    • Catheter-based angiography in 2004-2005: A reassessment of risk and complications.

      Kirmani JF, Khan S, Georgiadis AL, Al-Kawi A, Malik AK, Ezzeddine MA

    • Prospective evaluation of 102 patients with ischemic stroke undergoing catheter-based aortography reveals a low prevalence of moderate to severe supra-aortic great vessel atherosclerotic disease.

      Kirmani JF, Malik AK, Khan S, Georgiadis AL

    • Prevalence of acute hypertension in patients presenting to the emergency room with stroke in the United States.

      Qureshi AI, Ezzeddine MA, Nasar A, Georgiadis AL, Suri MFK, Hoonjan A, et al.

    • Mechanical thrombectomy following intravenous thrombolysis for ischemic stroke is safe and promotes recanalization.
      [Previously Presented]

      Qureshi AI, Kirmani JF, Janjua N, Al-Kawi A, Georgiadis AL, Harris-Lane P

    American Stroke Association
    2006 International Stroke Conference in Kissimmee, Fla. (Feb. 16-18, 2006)

    • A combination of computed tomographic scan findings and stroke severity can accurately identify the time interval between symptom onset and evaluation.

      Georgiadis AL, Suri MFK, Janjua N, Ezzeddine MA

    • Delayed angiographic recanalization and re-occlusion impacts on outcome in patients treated with thrombolytics for acute ischemic stroke.

      Janjua N, Nasar A, Harris-Lane P, Al-Kawi A, Georgiadis AL

    • Potential mechanisms for protective effects of beta-blockers in acute stroke patients.

      Laowattana S, Kent T

    • A systematic review of mortality and functional outcome in catheter-based therapy for acute ischemic stroke: comparison to predictive models.

      Mandava P, Kent TA

    • Relationship between admission glucose and outcome in the intravenous abciximab/heparin in acute stroke phase 1 study.

      Martini S, Anderson JA, Mandava P, Kent TA

    • Is a maximum dose of 90 mg of recombinant tissue plasminogen activator in patients weighing greater than 90 kg justified?

      Qureshi AI, Alkawi AM, Georgiadis AL, Ibrahim MS

    • Acute hypertension in 574,494 patients presenting to the emergency room with stroke in the United States.

      Qureshi AI, Ezzeddine MA, Nasar A, Georgiadis AL, Suri MFK, Hoonjan A

    • Mechanical thrombectomy following intravenous thrombolysis for ischemic stroke is safe and promotes recanalization.

      Qureshi AI, Kirmani JF, Janjua N, Al-Kawi A, Georgiadis AL, Harris-Lane P

    • A prospective study to assess the safety and efficacy of intra-arterial reteplase and intravenous abciximab in patients treated with thrombolytics for acute ischemic stroke.

      Qureshi AI, Kirmani JF, Janjua N, Georgiadis AL, Harris-Lane P

    • Treatment of subarachnoid hemorrhage with human albumin.

      Suarez JI, Harbaugh RE, Macdonald RL, Martin R, Palesch YY, Pina IL, et al.

    • Effect of intravenous infusion of adenosine upon clinical outcome of comatose survivors of cardiac arrest.

      Suarez JI, Hejal R, Rowbottom J, Lynch G, Pompilii V, Zivot J, et al.

    • Utilization of thrombolysis among patients with central retinal artery occlusion in the United States.

      Suri MFK, Qureshi AI, Georgiadis AL

    Texas Scottish Rite Hospital for Children
    28th Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 16-17, 2006)

    • Progressive numbness and weakness in a diabetic patient: Is it all diabetic neuropathy?

      Kwan J, Harati Y

    • Spontaneous mutilating acral ulcers in nondiabetic patients: The spectrum of differential diagnosis.

      Kwan J, Harati Y, Phan C

    International Neuropsychological Society (INS)
    34th Annual Meeting in Boston, Mass. (Feb. 1-4, 2006)

    Mashad University of Medical Sciences
    Seminars in Infectious Diseases (2006)

    • Efficacy of tetracycline versus azithromycin in combination with bismuth, metronidazole, and proton pump inhibitor for treatment of Helicobacter pylori infection.

      Jalali N, Karimi I

    American Epilepsy Society (AES)
    59th Annual Meeting in Washington, DC (Dec. 2-6, 2005)

    2nd International Congress on Multiple Sclerosis
    Tehran, Iran (Nov. 20, 2005)

    • Marriage and multiple sclerosis.

      Parsi H, Lotfi J, Sahraian M, Zohrevand P, Heshmat A

    • Vaccination in multiple sclerosis: vice or virtue (articles review).

      Sahraian M, Mottamedi M, Parsi H, Zohrevand P, Heshmat A

    • Multiple sclerosis and education: a demographic study.

      Zohrevand P, Alikhani K, Parsi H, Heshmat A

    Society for Neuroscience (SFN)
    35th Annual Meeting in Washington, DC (Nov. 12-16, 2005)

    XVIII World Congress of Neurology (WCN)
    Sydney, Australia (Nov. 4-11, 2005)

    • Cauda equina tumor presenting with communicating hydocephalus.

      Alibhoy A, Wijemanne S, Fernando N, Gamage R

    • Is control of elevated blood pressure in primary intracerebral hemorrhage a predictor of neurological deterioration?

      Suarez JI, Suri MFK, Rodrigue T, Wensel A, Bambakidis N, Echeverri JC, et al.

    • Impact of a specialized neurocritical care team on outcome and length of stay of critically ill acute ischemic stroke patients.

      Suarez JI, Suri MFK, Zaidat OO, Feen ES, Georgiadis A, Lynch G, et al.

    • Young-onset Parkinson's disease - A Sri Lankan profile.

      Wijemanne S, Alibhoy A, Fernando N, Gamage R

    Mexican Academy of Neurology
    29th Annual Meeting in Chihuahua, Mexico (Oct. 29 - Nov. 3, 2005)

    American Neurological Association (ANA)
    130th Annual Meeting in San Diego, Calif. (Sept. 25-28, 2005)

    • Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

      Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

    • Botulinum toxin type B Observational Study (BOS).

      Jankovic J, Hunter CB, the BOS Study Group

    Michael E. DeBakey Veterans Affairs Medical Center
    Nurse Education Lecture Series in Houston, Texas (Sept. 9, 2005)

    • The nurse's role in diagnosis and treatment of acute stroke.

      Anderson J

    19th European Drosophila Research Conference
    Eger, Hungary (Aug. 31 - Sept. 3, 2005)

    • Interactions among bHLH proteins in SOP specification.

      Zarifi I, Giagtzoglou N, Delidakis C

    European Federation of Neurological Societies (EFNS)
    20th Annual National Conference in Fort Lauderdale, Fla. (June 17-21, 2005)

    • A novel approach in transitional cardiac rehabilitation.

      Anderson J, Willson P

    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    2nd Alzheimer's Association International Conference (AAIC)
    Washington, DC (June 9-12, 2005)

    • Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

      Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

    • Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard-ratio analysis.

      Thal LJ, Thomas RG, Grundman M, Bennett DA, Doody RS, Ferris SH, et al.

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2005, 22nd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Amsterdam, The Netherlands (June 7-11, 2005)

    • Ultrasound-augmented thrombolysis improves outcome in hyperglycaemic stroke.
      [Platform Presentation]

      Martini S, Hill MD, Alexandrov AV, Molina CA, Kent TA

    • Oxygen treatment after perinatal hypoxia-ischemia reduces neuronal damage at short survival times, but worsens injury with long-term survival.
      [Platform Presentation]

      Noppens KM, Perez-Polo JR, Rassin DK, Westlund KN, Fabian R, Kent TA, et al.

    16th Congress of Iranian Internal Medicine
    Tehran, Iran (May 2005)

    • Comparison of predisposing factors of DKA in two studies.
      [Oral Presentation]

      Zohrevand P, Esfehaniyan F, Nakhjavani M

    Association for Research in Vision and Ophthalmology (ARVO)
    2005 Annual Meeting in Fort Lauderdale, Fla. (May 1-5, 2005)

    • Superior limbic keratoconjunctivitis in chronic ocular graft vs. Host disease.

      Kim SK, Couriel D, Ghosh S, Khaleeq A, Pflugfelders SC

    American Telemedicine Association (ATA)
    10th Annual Meeting in Denver, Colo. (April 17-20, 2005)

    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    American Academy of Neurology (AAN)
    57th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)

    • Genetic analysis of G309D and W4370PA mutations of PINK1 in Parkinson's disease.

      Deng H, Le W, Zhang X, Pan T, Jankovic J

    • New version of the UPDRS: Development methods and working document for field testing.

      Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins G, et al.

    • A variant in the HS1-BP3 gene is associated with familial essential tremor.

      Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Tan EK, Rooney JP

    • Mild cognitive impairment types and their outcomes.

      Issa A, Rountree S, Waring S, Yeh S, Doody RS

    • ADAS-Cog change rates in MMSE Strata relevant to clinical trials.

      Massman P, Doody RS

    • Convergence spasm and other psychogenic eye movement disorders.

      Mejia NI, Jankovic J

    • Tics associated with other disorders.

      Mejia NI, Jankovic J

    • HSP70 inducer VPA inhibits rotenone-induced apoptosis in SH-SY5Y cells.

      Pan T, Xie W, Jankovic J, Le W

    • Relationship of premorbid IQ and education to progression of Alzheimer's disease.

      Pavlik V, Doody RS, Massman P, Chan W, Yeh S

    • Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
      [Previously Presented]

      Shahed J, Diamond AL, Vuong KD, Jankovic J

    • Botulinum toxin treatment for oromandibular dystonia and bruxism in patients with Tourette syndrome.

      Silay YS, Jankovic J

    Leiden International Medical Student Congress (LIMSC)
    2nd Annual Meeting in Leiden, The Netherlands (April 7-9, 2005)

    • Significance of coronary disease among patients with diabetes.

      Stosic M, Igic M

    Veterans Health Administration
    Care Coordination and Leadership Forum in Salt Lake City, Utah (April 5, 2005)

    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    15th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID)
    Copenhagen, Denmark (April 2-5, 2005)

    • Seroepidemiology of Crimean-Congo hemorrhagic fever in local and imported sheep in Isfahan province, Iran in 2002.

      Darvishi M, Ataee B, Chinikar S, Jalali N, Mardani M, Mirkhani M

    Central Texas Veterans Health Care System
    19th Annual Nursing Research Day in Waco, Texas (April 1, 2005)

    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Michael E. DeBakey Veterans Affairs Medical Center
    Advanced Cardiac Life Support Course in Houston, Texas (April 1, 2005)

    • Brain attack - Time lost is brain lost.

      Anderson J

    VA Research Day
    Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas (March 29, 2005)

    • Determining preoperative indicators for transitional cardiac rehabilitation after heart surgery.

      Anderson J, Willson P

    • Videophone exercise motivation for peripheral arterial disease patients.

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Movement Disorder Society (MDS)
    9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)

    Neurocritical Care Society (NCS)
    3rd Annual Meeting in Scottsdale, Ariz. (Feb. 25-27, 2005)

    • Seizures after intravenous iohexol for cerebral angiography.

      Cardenas J, Lazaridis C, Unwin H

    • Combined intravenous and intra-arterial thrombolysis in acute middle cerebral artery occlusion (MCAO).

      Lazaridis C, Cardenas J, Unwin H

    • CHILI: Controlled hypothermia in large infarction.

      Sung G, Castaldo J, Terry J, Coplin W, Mayer S, Qureshi AI, et al.

    • Hyperglycemia as independent predictor of acute neurological deterioration after intracerebral hemorrhage.

      Suri MF, Suarez JI, Rodrigue TC, Zaidat OO, Wensel A, Bambakidis N, et al.

    Texas Scottish Rite Hospital for Children
    27th Annual Carrell-Krusen Symposium in Dallas, Texas (Feb. 24-25, 2005)

    • Reversible myeloneuropathy due to vitamin B12 deficiency compounded by administration of nitrous oxide.
      [Platform Presentation]

      Lazaridis C, Singer M, Wolfe GI

    Texas Neurological Society
    2005 Winter Conference in Austin, Texas (Feb. 11-13, 2005)

    • Bilateral third nerve palsy and temporal arteritis.
      [Platform Presentation]

      Lazaridis C, Torabi A, Cannon S

    International Neuropsychological Society (INS)
    33rd Annual Meeting in St. Louis, Mo. (Feb. 2-5, 2005)

    American Stroke Association
    30th International Stroke Conference in New Orleans, La. (Feb. 2-4, 2005)

    • Resolution of "Dense Dot Sign" after acute ischemic stroke is associated with better outcome.

      Mandava P, Kent TA

    • Faster and complete recanalization may overcome the negative effect of hyperglycemia on stroke outcome.

      Martini SR, Hill M, Alexandrov A, Molina C, Kent TA

    8th Joint Meeting of the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), and the American Society of Interventional and Therapeutic Neuroradiology (ASITN)
    New Orleans, La. (Feb. 1-4, 2005)

    • A retrospective study of the prevalence and appropriatness of intravenous heparin use for ischemic stroke in Hispanics and African Americans in an urban hospital community: A regional population study.
      [Platform Presentation]

      Ahmed S, Kirmani JF, Ammar A, Syed FA, Siddiqui A, Szapiel SV, et al.

    • Qureshi grading scheme for angiographic occlusions correlates with favorable outcome following intra-arterial thrombolysis for acute ischemic stroke.

      Suri MFK, Suarez JI

    • Endovascular intra-arterial thrombolytic therapy in the post cardiac catheterization stroke.

      Zaidat OO, Alexander MJ, Mohammed Y, Christoforidis GA, Ionita C, Graffagnino C, et al.

    American Epilepsy Society (AES)
    58th Annual Meeting in New Orleans, La. (Dec. 3-7, 2004)

    • Utility of intermittent bedside electroencephalographic monitoring in the pediatric intensive care setting.

      Richards KC, Hrachovy RA, Mizrahi EM, Jefferson LS

    American Neurological Association (ANA)
    129th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)

    Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
    18th Annual Symposium in Toronto, Canada (Oct. 3, 2004)

    European Federation of Neurological Societies (EFNS)
    8th Congress in Paris, France (Sept. 4-7, 2004)

    • Donepezil is safe and well-tolerated in AD patients at doses of up to 20 mg/day.

      Schindler R, Corey-Bloom J, Doody R, Zhang R, Leni JR, Li H

    • Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.

      Wirth Y, Doody RS, Schmitt FA, Mobius HJ, Stoffler A

    9th International Conference on Alzheimer's Disease and Related Disorders
    Philadelphia, Penn. (July 17-22, 2004)

    • Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits.

      Doody R, Pratt R, Posner H, Kumar D

    • Longitudinal analysis of the Alzheimer's Disease assessment scale in a large cohort of probable AD patients.

      Massman P, Doody R

    • Memantine treatment for mild to severe Alzheimer's disease: Clinical trials summary.

      Tariot P, Doody R, Peskind E, Winblad B, Reisberg B, Stoffler A, et al.

    • Functional benefits of memantine treatment for patients with moderate to severe Alzhemier's disease.

      Wirth Y, Doody RS, Schmitt FA, Mobius HJ

    North American Fuzzy Information Processing Society (NAFIPS)
    2004 IEEE Annual Meeting in Banff, Alta., Canada (June 27-30, 2004)

    • A fuzzy rule based approach to identify brain structures using MRI, in the presence of individual anatomical differences.

      Kent TA, Hillman GR

    International Stroke Society (ISS)
    5th World Stroke Congress in Vancouver, British Columbia, Canada (June 23-26, 2004)

    • Intravenous abciximab in complicated cardioembolic stroke patients with high NIHSS.

      Mandava P, Lick SD, Rahman AM, Kent TA

    XXIVth Collegium Internationale Neuro-Psychopharmacologicum (CINP) Congress
    Paris, France (June 20-24, 2004)

    • Memantine treatment is beneficial for functional capacities of patients with moderate to severe Alzheimer's disease.

      Wirth Y, Doody R, Schmitt F, Mobius HJ, Stoffler A

    International Stroke Society (ISS)
    8th International Symposium on Thrombolysis and Acute Stroke Therapy in Whistler, British Columbia, Canada. (June 19-22, 2004)

    • Reversibility of dense CT "dot" sign predicts recovery after abciximab and heparin.

      Mandava P, Reddy K, Kent TA

    Movement Disorder Society (MDS)
    8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)

    International Medical Sciences Student Congress (IMSSC)
    19th Annual Meeting in Istanbul, Turkey (May 6-9, 2004)

    • Traditional education modalities of present anatomy curriculum in Belgrade Medical School.

      Stosic M, Tomic A, Kresojevic N, Milenkovic P, Popovic D

    American Academy of Neurology (AAN)
    56th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)

    • Camptocormia: Pathogenesis, classification and response to therapy.

      Azher S, Jankovic J

    • Interim results of an observational study of neutralizing antibody formation with the current preparation of botulinum toxin type A treatment for cervical dystonia.

      Comella CL, Jankovic J, Daggett S, Mordaunt J, Brin MF

    • Haplotype analysis at the ETM2 locus in American and Singaporean populations with familial essential tremor.

      Higgins JJ, Lombardi RQ, Tan EK, Jankovic J, Pucilowska J, Rooney JP

    • Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.

      Hunter CB, Vuong KD, Jankovic J

    • Essential tremor in children.

      Jankovic J, Madisetty J, Vuong KD

    • Psychogenic tremor: Long-term outcome.

      Jankovic J, Vuong KD, Thomas M

    • Effects of ropinirole on progression of parkinsonism in Nurr1-deficient mice and its underlying mechanisms.

      Jiang C, Pan T, Jankovic J, Le W

    • Dopaminergic properties and anti-parkinsonian effects of IPX750 in rodent models of Parkinson's disease.

      Jiang C, Wan X, Jankovic J, Christian S, Sundsmo J, Le W

    • The utility of EEG in early diagnosis of herpes simplex encephalitis.

      Kocharian N, Suarez JI, Alshekhlee A

    • Predictors of clinical worsening within 24 hours of acute ischemic stroke onset in patients receiving thrombolysis therapy.

      Leigh R, Suarez JI, Zaidat OO, Lynch G, Suri MF, Sunshine JL, et al.

    • Endovascular recanalization predicted clinical outcome in 96 acute ischemic stroke patients treated with intra-arterial and combined intravenous and intra-arterial recombinant tissue plasminogen activator (rtPA).

      Moro M, Zaidat OO, Suarez JI, Welter E, Tarr RW, Sunshine JL, et al.

    • The prevalence of hyperglycemia in the neurointensive care unit and its effects on length of stay and cost of care.

      Nagaraddi V, Lynch GF, Suri FM, Suarez JI

    • The pharmacological and biological effects of pramipexole on dopamine transporter.

      Pan T, Jankovic J, Le W

    • Decreased Nurr1 mRNA in peripheral blood lymphocytes in Parkinson's disease.

      Pan T, Xie W, Jankovic J, Le W

    • The efficacy and safety of fluphenazine in patients with Tourette syndrome.

      Silay YS, Vuong KD, Jankovic J

    • A double-blind, randomized, parallel group design comparison of botulinum toxin, type A (Botox®) and botulinum toxin, type B (Myobloc™) on autonomic symptoms and physiology in patients with cervical dystonia.

      Tintner R, Winzer UF, Smalky KA, Jankovic J

    • Temporal course of the motor effects of subthalamic DBS after stopping stimulation.

      York MK, Lai EC, Soety EM, Atassi F, Grossman RG, Simpson Jr RK

    • Combined intravenous and intra-arterial versus intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke patients: propensity score analysis.

      Zaidat OO, Welter E, Suarez JI, Kocharian N, Suri FMK, Alexander MJ, et al.

    Pontificia Universidad Catolica del Ecuador (PUCE)
    IV Anuario de la Facultad de Medicina (April 2004)

    • The relationship between IgG and IgA serology for chlamydia pneumoniae and first ever ischemic stroke.

      Ramirez JL, Ontaneda D, DiCapua DR

    American Society for Experimental NeuroTherapeutics (ASENT)
    6th Annual Meeting in Bethesda, Md. (March 11-13, 2004)

    Society of Critical Care Medicine (SCCM)
    33rd Annual Congress in Orlando, Fla. (Feb. 20-25, 2004)

    • Effect of a neurocritical care team on readmission of critically ill stroke patients.

      Georgiadis A, Suarez JI, Zaidat OO, Suri MF, Lynch G

    • Effect of human albumin on outcome and cost in patients with subarachnoid hemorrhage.

      Suarez JI, Shannon L, Zaidat OO, Singh G, Lynch G, Suri MF, et al.

    American Stroke Association
    29th International Stroke Conference in San Diego, Calif. (Feb. 5-7, 2004)

    • Angiographic grading scheme predicts functional outcome in patients with ischemic stroke undergoing intra-arterial thrombolysis.

      Suri MFK, Zaidat OO, Suarez JI

    International Neuropsychological Society (INS)
    32nd Annual Meeting in Baltimore, Md. (Feb. 4-7, 2004)

    7th Joint Meeting of the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), and the American Society of Interventional and Therapeutic Neuroradiology (ASITN)
    San Diego, Calif. (Feb. 1-4, 2004)

    • Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: propensity score analysis.

      Zaidat OO, Suarez JI, Welter E, Love TE, Tarr RW,mSunshine JL, et al.

    Isfahan University of Medical Sciences
    Seminars in Infectious Diseases (2004)

    • Effectiveness of one week of parenteral plus three weeks of oral antibiotic treatment in patients with resistant chronic sinusitis.

      Jalali N, Karimi I

    American Epilepsy Society (AES)
    57th Annual Meeting in Boston, Mass. (Dec. 5-10, 2003)

    • Regional and developmental localization of ion-channel genes coexpressed in heart and brain.

      Goldman AM, Burgess DL, Armstrong DD, Mori M, Noebels JL

    • Persistent changes in seizure susceptibility and gabaergic neurotransmission after recurrent early-life seizures.

      Kim DK, Hrachovy RA, Swann JW

    • Expression of apoptosis inhibitor protein MCL1 linked to neuroprotection in CNS neurons.

      Mori M, Burgess DL, Gefrides LA, Armstrong D, Foreman PJ, Opferman JT, et al.

    • Presidential symposium: The developing epileptic brain.

      Noebels JL, Walsh CA, Levitt PR, Barres BA

    • Elevated T-type calcium currents in thalamic neurons are associated with spike-wave seizure generation in the mouse mutant Coloboma (Cm/+).

      Zhang Y, Vilaythong AP, Noebels JL

    Society for Neuroscience (SFN)
    33rd Annual Meeting in New Orleans, La. (Nov. 8-12, 2003)

    • Anterior thalamus interaction with the retrosplenial cortex in the anaesthetized rat.

      Albo Z, Ding M, Vertes RP, Viana Di Prisco G

    • Estrogen and μ-opiates: modulators of cocaine induced locomotor sensitization in female rats.

      Diaz GE, Hernandez PJ, Segarra AC, Luciano CA

    • Naloxonazine, a mu opioid antagonist, increases MOR in the VTA of estrogen treated rats.

      Menéndez-Delmestre R, Hernandez PJ, Diaz GE, Segarra AC

    25th International Epilepsy Congress (IEC)
    Lisbon, Portugal (Oct. 12-16, 2003)

    • Expression pattern of candidate epilepsy ion channel genes in mouse and human brains.

      Goldman AM, Burgess DL, Armstrong DD, Mori M, Noebels JL

    International Brain Research Organisation (IBRO)
    6th World Congress on Neuroscience in Prague, Czech Republic (July 10-15, 2003)

    • Coherence analysis of anterior thalamic unit firing with retrosplenial cortical and hippocampal theta rhythm.

      Albo Z, Viana Di Prisco G, Ding M, Vertes RP

    Canadian Congress of Neurological Sciences (CCNS)
    38th Annual Meeting in Quebec City, Canada (June 17-21, 2003)

    • Diagnosing vertebral artery dissection in the emergency department.

      Phan C, Stewart B

    2nd World Congress of Nephrology
    Organised jointly with ISN, ESPN, EKRA, GfN and DAGKN in Berlin, Germany (June 8-12, 2003)

    • Effectiveness of metronidazole on cyclosporine-induced gingival hyperplasia in bone marrow and kidney transplant patients: a prospective, double-blinded controlled clinical trial.

      Heshmat A, Najafi I, Moghadam K, Iravani M, Yunesiyan M, Zohrevand P

    American Academy of Neurology (AAN)
    55th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)

    • Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-Based Impression of Change-Plus version: A comparison of Alzheimer's disease versus vascular dementia.

      Doody RS, Pratt RD, Perdomo CA, the Donepezil 307 and 308 vaD Study Groups

    • Predicting mechanical ventilation in myasthenia gravis exacerbation.

      Feen ES, Suarez JI, Zaidat OO, Bonnyapisit K, Suri MFK, Kaminski HJ, et al.

    • Long-term treatment with the NMDA antagonist, memantine: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease.

      Ferris SH, Schmitt FA, Doody RS, Moebius H-J, Stoeffler A, Reisberg BJ

    • Haplotype analysis of unrelated individuals with familial essential tremor.

      Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, et al.

    • Comparison of postoperative improvement of staged bilateral subthalamic stimulation in patients with advanced Parkinson's disease.

      Kuniyoshi S, Tintner R, Ondo W, Simpson R, Jankovic J

    • Apolipoprotein E controls risk and age at onset of Parkinson disease.

      Li Y-J, Martin ER, Scott WK, Haines JL, Nance MA, Hubble JP, et al.

    • Glutathione S-Transferase, Omega-1 (GSTO1) modifies age at onset of Alzheimer disease and Parkinson disease.

      Li Y-J, Oliveria AS, Hauser MA, Hauser ER, Scott WK, Stenger JE, et al.

    • A double blind placebo controlled parallel trial of botulinum toxin B (Myobloc™) for the treatment of sialorrhea in parkinson disease.

      Ondo WG, Hunter CB, Moore W

    • Clinical and laboratory features of west nile meningoencephalitis.

      Robinson J, Eccher M, Suarez JI, Zaidat OO, Preston DC, Shapiro BE, et al.

    • Predictors of in-hospital mortality in neurocritically-ill patients.

      Suarez JI, Zaidat OO, Suri MFK, Feen ES, Lynch G, Hickman J, et al.

    • Induced hypothermia for treatment of severe head injury: meta-analysis of randomized trials.

      Suri MFK, Qureshi AI, Safdar A, Kirmani JF, Xavier AR, Siddiqui AM, et al.

    • The epidemiology of myoclonus in the medical and surgical intensive care unit (ICU).

      Tintner R, Kuniyoshi SM, Gonzalez A, Jankovic J

    • Specific mitochondrial haplogroups affect risk for late-onset Parkinson disease.

      Van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Haines JL, McLaurin AC, et al.

    • Dual-task functioning in mild and moderately severe Parkinson's disease patients.

      York MK, Lai EC, Levin HS, Grossman RG

    • Initial ischemic stroke severity and 3 months outcome predicted by aortic atheroma location and morphology as detected by cardiac cycle gated and contrasted chest tomography.

      Zaidat OO, Suarez JI, Gilkeson RC, Sunshine JL, Tarr RW, Selman WR, et al.

    Genetics Society of America (GSA)
    43th Annual Drosophila Research Conference in Chicago, Ill. (March 5-9, 2003)

    • Two modes of recruitment of E(spl) repressors onto target genes.

      Giagtzoglou N, Alifragis P, Koumbanakis K, Delidakis C

    American Stroke Association
    28th International Stroke Conference in Phoenix, Ariz. (Feb. 13-15, 2003)

    • Intra-arterial thrombolytic therapy within three hours of stroke onset.

      Bourekas EC, Shah R, Christoforidis G, Mohammad YM, Suarez JI, Tarr RW, et al.

    • Predictors of hyperacute clinical worsening in acute ischemic stroke patients receiving thrombolysis.

      Leigh R, Suarez JI, Zaidat OO, Suri MF, Sunshine JL, Tarr RW, et al.

    • A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage.

      Qureshi AI, Mohammad YM, Suarez JI, Siddiqui AM, Kirmani JF, Suri MFK, et al.

    • Prediction of functional outcome following spontaneous intracerebral hemorrhage in adults: a proposed grading system.

      Rodrigue TC, Suarez JI, Zaidat OO, Wensel A, Bambakidis N, Echeverri JC

    • The interventional management of stroke study (IMS): factors associated with ICH.

      The IMS Investigators

    • The interventional management of stroke study (IMS): safety results.

      The IMS Investigators

    • Interventional management of stroke: relationship of occlusive lesion to outcome.

      The Interventional Management of Stroke Investigators

    • The first recorded mean arterial blood pressure predicts death and neurological outcome in patients with non-traumatic intracerebral hemorrhage.

      Zaidat OO, Suarez JI, Rodrigue TC, Bambakidis N, Wensel A, Echeverri JC, et al.

    International Neuropsychological Society (INS)
    31th Annual Meeting in Honolulu, Hawaii (Feb. 5-8, 2003)

    American Society for Cell Biology (ASCB)
    42nd Annual Meeting in San Francisco, Calif. (Dec. 14-18, 2002)

    • Differential C/EBP expression after stroke.

      Bolanos S, Saito H, Papaconstantinou J, Perez-Polo JR, Kent TA

    American Epilepsy Society (AES)
    56th Annual Meeting in Seattle, Wash. (Dec. 6-11, 2002)

    • Utility of continuous video-EEG monitoring in a veteran population: Review of 144 consecutive patients.

      Foreman PJ, Wilder LM, Hrachovy RA

    • Incidence of hippocampal sclerosis in Rochester, Minnesota, 1990-1996.

      Goldsmith IL, Buchhalter JR

    • EEG abnormalities and epilepsy in Smith-Magenis syndrome and in a genetic mouse model.

      Lynch JK, Walz K, Glaze DG, Potocki L, Lupski JR, Noebels JL

    • The effect of topiramate on excitatory synaptic transmission in mouse hippocampus.

      Qian J, Noebels JL

    Movement Disorder Society (MDS)
    7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)

    • Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.

      Hill AN, Jankovic J, Vuong KD, Donovan D

    • Age-related tolerability of tetrabenazine.

      Hunter CB, Wang A, Vuong KD, Jankovic J

    • Tetrabenazine in the treatment of Tourette syndrome.

      Hunter CB, Wang A, Vuong KD, Jankovic J

    • Premonitory sensations in tics.

      Kwak CH, Jankovic J

    • Reduced Nurr1 expression increases the susceptibility to dopaminergic toxins via nitric oxide.

      Le W, Imam SZ, Xie W, Ali S, Jankovic J

    • Computerized posturography balance assessment of patients with bilateral vim deep brain stimulation.

      Ondo WG, Cohen H, Almaguer M, Jankovic J

    • Upregulation of Nurr1 gene expression by dopamine receptor agonist pramipexole in human neuroblastoma SHSY-5Y cells.

      Pan TH, Xu PY, Xie WJ, Hunter C, Jankovic J, Le WD

    • Reliability of limits of stability measures in Parkinson's disease.

      Protas EJ, Thomas M, Cunha IT, Caroline KS, Wankadia S, Jankovic J

    • Minocycline in Huntington's disease: A pilot study.

      Thomas M, Ashizawa T, Jankovic J

    • Gait and Balance Scale (GABS): Validation and utilization.

      Thomas M, Jankovic J, Suteerawattanon M, Wankadia S, Caroline K, Protas E

    • Experience with bilateral subthalamic nucleus (STN) stimulation for Parkinson's disease (PD).

      Tintner R, Almaguer M, Sanghera M, Simpson R, Ondo WG, Jankovic J

    • Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.

      Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M

    • Pleuropulmonary fibrosis after 11 years of pergolide treatment.

      Tintner R, Manian P, Gauthier P, Jankovic J

    • The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study.

      Truong DD, Duane DD, Jankovic J, Singer C, Comella CL, the US Dysport Dystonia Study Group

    • Working memory functioning in mild and moderately severe Parkinson's disease patients.

      York MK, Lai EC, Levin HS, Grossman RG

    American Neurological Association (ANA)
    127th Annual Meeting in New York City, N.Y. (Oct. 12-16, 2002)

    • Dystonia in Friedreich's ataxia.

      Hou JG, Jankovic J

    Barany Society
    6th NASA Symposium on The Role of the Vestibular Organs in the Exploration of Space (Sept. 30 - Oct. 3, 2002)

    • Assessment of neurologic function following short duration spaceflight utilizing a standardized rating scale.

      Clark JB

    • Neurovestibular effects of long-duration spaceflight: a summary of Mir phase 1 experiences.

      Richards JT, Clark JB, Oman CM, Marshburn TH

    8th International Conference on Alzheimer's Disease and Related Disorders
    Stockholm, Sweden (July 20-25, 2002)

    • How well do cerebral spinal fluid tau levels discriminate autopsy confirmed Alzheimer's disease from other dementia diagnoses?

      Clark C, Eubank D, Peskind E, Galasko D, Morris J, McKeel D, et al.

    • Pathogenesis and treatment strategies for selected therapies under development.

      Doody RS

    • Long term treatment with the NMDA antagonist memantine: results of a 24-week, open label extension study in moderately severe to severe Alzheimer's disease.

      Reisberg B, Mobius H, Stoffler A, Schmitt F, Doody R, Ferris S

    Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
    International Conference in Hannover, Germany (June 8, 2002)

    Society for Academic Emergency Medicine (SAEM)
    Annual Meeting in St. Louis, Mo. (May 19-22, 2002)

    • Subarachnoid hemorrhage: effect of published guidelines on compliance and mortality.

      Duldner E, Bear T, Metzger V, Korytko T, Suyama J, Pancioli A, et al.

    World Federation of Neurology (WFN)
    Research Group on Neuroepidemiology. Regional North American Annual Meeting in Denver, Colo. (April 19, 2002)

    • Survival in patients with dementia from a large multi ethnic population.

      Waring S, Doody RS

    American Academy of Neurology (AAN)
    54th Annual Meeting in Denver, Colo. (April 13-20, 2002)

    • Stroke free survival and its determinants in patients with symptomatic vertebrobasilar stenosis.

      Mohammad Y, Qureshi AI, Suri MFK, Yahia AM, Zaidat OO, Suarez JI, et al.

    International Neuropsychological Society (INS)
    30th Annual Meeting in Toronto, Canada (Feb. 13-16, 2002)

    • Neuropsychological test scores among complicated mild head injury subtypes.

      Collins RL, Hannay HJ, Cass J, Valadka A

    • Growth curve analysis of decline in instrumental activities of daily living in AD patients.

      Davis R, Atchison T, Massman P, Doody R

    • Measurement invariance of theWAIS-R in AD among patients at higher versus lower levels of dementia severity.

      Davis R, Massman P, Doody R

    • WAIS-R factor structure in AD: Comparison of alternative models and assessment of generalizability.

      Davis R, Massman P, Doody R

    American Stroke Association
    27th International Stroke Conference in San Antonio, Texas (Feb. 7-9, 2002)

    • The utility of ultrafast cardiac cycle gated and contrasted spiral computerized axial chest tomography in evaluation of patients with acute stroke and comparison with transesophageal echocardiography.

      Zaidat OO, Suarez JI, Gilkeson R, Sunshine J, Tarr R

    • Direct evidence for C/EBP regulation of synaptic development.

      Bolanos S, Saito H, Papaconstantinou J, Perez-Polo JR, Kent TA

    • Impact of DWI/PWI MRI on therapeutic decision making in hyper-acute ischemic stroke.

      Suarez JI, Schoenberger A, Zaidat OO, Tarr RW, Sunshine JL, Selman WR, et al.

    Society of Critical Care Medicine (SCCM)
    31st Annual Congress in San Diego, Calif. (Jan. 26-30, 2002)

    • Predictors of functional outcome upon discharge in patients with myasthenia gravis exacerbation.

      Suarez JI, Boonyapisit K, Kaminski HJ, Zaidat OO, Ruff RL

    University of Puerto Rico
    Minority Biomedical Research Support Summer Poster Day in Rio Piedras, Puerto Rico (2002)

    • Estrogen and μ-opiates: modulators of cocaine induced locomotor sensitization in female rats.

      Diaz GE, Hernandez PJ, Segarra AC, Luciano CA

    American Epilepsy Society (AES)
    55th Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 5, 2001)

    • Neurological impairment, developmental delay and postneonatal seizures two years after EEG-video documented seizures in near-term and full-term neonates: Report of the clinical research centers for neonatal seizures.

      Mizrahi EM, Clancy RR, Dunn JK, Hirtz D, Chapieski L, McGuan S, et al.

    • Ketamine for refractory status epilepticus: a case of suspected ketamine-induced neurotoxicity.

      Ubogu E, Reed D, Sagar S, Lerner A, Maddux B, Suarez JI, et al.

    • Vagus nerve stimulation: Correlation of changes in spike morphology with seizure control.

      Verma A, Mizrahi EM, Frost JD Jr

    • The effect of ammon's horn sclerosis and atypical sclerosis on seizure frequency following temporal lobectomy.

      York MK, Mizrahi EM, Levin HS, Armstrong DD, Rettig GM, Hamilton WJ, et al.

    Society for Neuroscience (SFN)
    31th Annual Meeting in San Diego, Calif. (Nov. 10-15, 2001)

    • A study of neural interactions within the limbic system using partial coherence and direct transfer functions analysis.

      Albo Z, Viana Di Prisco G, Truccolo W, Vertes RP, Ding M

    17th European Drosophila Research Conference
    Edinburgh, Scotland (Sept. 1-5, 2001)

    • A novel regulatory mechanism involving interaction between two types of bHLH proteins.

      Giagtzoglou N, Alifragis P, Koumbanakis C, Tambakakis M, Delidakis C

    XVII World Congress of Neurology (WCN)
    London, United Kingdom (June 17-22, 2001)

    • Predictors of mechanical ventilation in patients with myasthenia gravis exacerbation.

      Suarez JI, Boonyapisit K, Zaidat OO, Kaminski HJ, Ruff RL

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2001, 20th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Taipei, Taiwan (June 9-13, 2001)

    • Transcription events in recovery from stroke.

      Bolanos S, Kent TA

    World Federation of Neurology (WFN)
    Research Group on Neuroepidemiology. Regional North American Annual Meeting in Philadelphia, Penn. (May 9, 2001)

    • Racial differences among patients with Alzheimer's disease from a large multi ethnic population.

      Waring S, Doody RS

    American Academy of Neurology (AAN)
    53rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)

    • The prevalence of restless legs syndrome in patients with Parkinson's disease.

      Atassi F, Vuong KD, Jankovic J, Ondo WG

    • The cognitive benefits of galantamine are sustained for at least 24 months: Results of a long-term extension trial in Alzheimer's disease.

      Doody RS, Kershaw P

    • Exploring the relationship between Parkinson's disease and restless legs syndrome.

      Ondo WG, Vuong KD, Jankovic J

    • Intraarterial thrombolysis for patients with acute ischemic stroke presenting after three hours of symptom onset.

      Suarez JI, Zaidat OO, Qureshi AI, Suri FK, Ali Z, Guterman LR, et al.

    American Medical Student Association (AMSA)
    51st Annual Convention in Anaheim, Calif. (March 28 - April 1, 2001)

    • Differences in open field behavior vary according to the stage of the estrous cycle in rats.

      Díaz G, Montalvo J, González LA, Febo M, González NY, González JL, et al.

    International Neuropsychological Society (INS)
    29th Annual Meeting in Chicago, Ill. (Feb. 14-17, 2001)

    • Outcome of complicated mild head injury subtypes.

      Hannay H, Collins R, Cass J, Valadka A

    American Stroke Association
    26th International Stroke Conference in Ft. Lauderdale, Fla. (Feb. 14-16, 2001)

    • Transcriptional regulation of synaptogenesis following stroke.

      Bolanos S, Papaconstantinou J, Saito H, Kent TA

    • Transcriptional responses in recovery from stroke.

      Bolanos S, Saito H, Papaconstantinou J, Kent TA

    • Safety of post-operative intra-arterial thrombolysis.

      Chalela JA, Katzan IL, Rasmussen PA, Liebeskind DS, Zaidat O, Suarez JI, et al.

    • Multicenter evaluation of the efficacy of endovascular treatment for symptomatic vasospasm unresponsive to hypervolemic and hypertensive therapy in patients with subarachnoid hemorrhage.

      Kim SH, Qureshi AI, Yahia AM, Suarez JI, Zaidat O, Ali Z, et al.

    • Cardiovascular complications in patients with massive middle cerebral artery infarction.

      Suarez JI, for the Massive Middle Cerebral Artery Infarction Review Group

    • Cerebral vasomotor reactivity in brain dead patients.

      Suarez JI, Zaidat OO

    • Risk of recurrent ischemic events in patients with symptomatic vertebro-basilar stenosis.

      Uzun G, Qureshi AI, Mohammad YM, Zaidat O, Suarez JI, Suri MFK, et al.

    Joint Meeting of the American Association of Neurological Surgeons (AANS), Congress of Neurological Surgeons (CNS), and the American Society of Interventional and Therapeutic Neuroradiology (ASITN)
    Cerebrovascular Disease in Hawaii 2001 in Waikoloa, Hawaii (Feb. 9-12, 2001)

    • A new grading system to evaluate intra-arterial occlusion and response to thrombolytics in patients with acute ischemic stroke.

      Qureshi AI, Ringer AJ, Kim SH, Lopes DK, Ali Z, Suri FK, et al.

    • Efficacy and safety of intra-arterial thrombolysis for acute ischemic stroke: a meta-analysis.

      Qureshi AI, Suri FK, Ali Z, Kim SH, Ringer AJ, Lopes DK, et al.

    • Timing of neurological deterioration in massive middle cerebral artery infarction: Implications for surgical intervention.

      Yahia AM, Qureshi AI, Suarez JI, Mohammad YM, Uzen G, Suri FK, et al.

    International League Against Epilepsy (ILAE)
    Hungarian Section Meeting (2001)

    • Median somatosensory evoked potential examinations in patients with primary generalized epilepsy.
      [Platform Presentation]

      Lazaridis C, Nagy F, Czopf J

    American Epilepsy Society (AES)
    54th Annual Meeting in Los Angeles, Calif. (Dec. 1-6, 2000)

    • Genetic aggregation of calcium channel defects in mice simulates non-mendelian inherited human epilepsy.

      Burgess DL, Gefrides LA, Davis CF, Noebels JL

    • Expression of a family of calcium channel γ-subunits (CACNG 1-8) in mice.

      Foreman PJ, Burgess DL, Gefrides LA, Noebels JL

    • Short-term outpatient video EEG monitoring: Results in 120 patients.

      Goldsmith IL, Britton JW, So EL

    • Absence of pilocarpine-induced status epilepticus in neurod knock out mice.

      Mori M, Min L, Ming TJ, Noebels JL

    • Changes in presynaptic Ca currents and transmitter release are synapse-dependent in epileptic mice with calcium channel mutations.

      Qian J, Noebels JL

    • Altered calcium currents in thalamocortical relay cells of stargazer, a mouse epilepsy model caused by a calcium channel gamma sub-unit mutation.

      Zhang Y, Noebels JL

    4th World Stroke Congress
    Melbourne, Australia (Nov. 25-29, 2000)

    • Mechanisms of synaptophysin expression following focal ischemic stroke.

      Bolanos S, Kent TA

    Society for Neuroscience (SFN)
    30th Annual Meeting in New Orleans, La. (Nov. 4-9, 2000)

    • Dynamical theta resonance between anterior thalamus and retrosplenial cortex in the anesthetized rat.

      Albo Z, Viana Di Prisco G, Vertes RP

    XIX Brazilian Congress of Neurology
    Salvador, Brazil (Oct. 7-12, 2000)

    • Modifiable exclusion criteria from thrombolysis in patients with acute ischemic stroke.

      Fernades Fihlo JA, Zaidat OO, Suarez JI

    • Thrombolytic agents in top of the carotid occlusion.

      Suarez JI, Fernandes Fihlo JA, Zaidat OO

    • Thrombolytic therapy in patients with acute carotid dissection.

      Zaidat OO, Fernandes Fihlo JA, Suarez JI

    7th International Conference on Alzheimer's Disease and Related Disorders
    Washington, DC (July 9-18, 2000)

    • Cholinesterase inhibitors: Benefits and limitations.

      Doody RS

    Movement Disorder Society (MDS)
    6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)

    • Olanzapine treatment for dopaminergic induced hallucinations.

      Ondo WG, Hunter C, Vuong KD, Jankovic J

    • Daytime sleepiness in patients with Parkinson's disease.

      Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J

    American Academy of Neurology (AAN)
    52nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)

    • Donepezil preserves activities of daily living in Alzheimer's disease patients: Results from a 1-year placebo-controlled functional survival study.

      Mohs R, Doody R, Morris J, Ieni J, Perdomo C, Pratt R

    • Early predictors of outcome in patients receiving hypervolemic and hypertensive therapy for symptomatic vasospasm following subarachnoid hemorrhage.

      Suarez JI, Qureshi AI, Bhardwaj A, Yahia Abutaher M, Tamargo RJ, Ulatowski JA

    • Profoundly advanced Alzheimer's disease: Patient characteristics, functional status, disease progression, and care burden.

      Sumaira R, Doody R, Lai EC

    • Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.

      Vuong KD, Ondo WG, Almaguer M, Simpson RK, Jankovic J

    • Timing of neurological deterioration in patients with massive middle cerebral artery stroke.

      Yahia AM, Qureshi AI, Suarez JI, Suri FK, Yousef MM, Weityck R

    International Society for Magnetic Resonance in Medicine (ISMRM)
    8th Annual Meeting in Denver, Colo. (April 1-7, 2000)

    • Effects of traumatic brain injury and mild hypovolemic systemic hypotension on cerebral vascular and tissue characteristics: A magnetic resonance imaging study.

      Williams JP, DeWitt DS, Quast MJ, Kent TA, Prough DS

    Genetics Society of America (GSA)
    41st Annual Drosophila Research Conference in Pittsburgh, Penn. (March 22-26, 2000)

    • A role for PAR-1 in oocyte determination.
      [Platform Presentation]

      Shulman JM

    American Stroke Association
    25th International Stroke Conference in New Orleans, La. (Feb. 10-12, 2000)

    • Temporal patterns of response to hypervolemic and hypertensive treatment in patients with symptomatic vasospasm following subarachnoid hemorrhage.

      Suarez JI, Qureshi AI, Yahia AM, Bhardwaj A, Tamargo RJ

    • Combined intravenous and intra-arterial thrombolysis therapy for acute ischemic stroke.

      Suarez JI, Zaidat OO, Sunshine JL, Tarr RW, Sundararajan S, Selman WR, et al.

    • The requirement for perfusion analysis in accurate mr triage of hyperacute stroke.

      Sunshine JL, Tarr RW, Suarez JI, Zaidat OO, Lewin JS, Landis DM

    American Society of Consultant Pharmacists (ASCP)
    30th Annual Meeting in St. Loius, Mo. (Nov. 10-13, 1999)

    • Uninterrupted long-term donepezil treatment results in optimal efficacy with retained safety.

      Doody R, Geldmacher DS, Pratt RD, Perdoma CA

    Society for Neuroscience (SFN)
    29th Annual Meeting in Miami Beach, Fla. (Oct. 23-28, 1999)

    • Re-entrant theta activity in Papez circuit: Role of the anterior ventral nucleus of the thalamus.

      Albo Z, Viana Di Prisco G, Vertes RP

    • Kappa-opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.

      Collins RL, Zavala AR, Nazarian A, McDougall SA

    • Patterns of neuronal activity in the median raphe during hippocampal theta rhythm in the anesthetized rat.

      Viana Di Prisco G, Albo Z, Vertes RP

    16th European Drosophila Research Conference
    Zurich, Switzerland (Sept. 29 - Oct. 2, 1999)

    • Transcriptional repression by E(spl) proteins.

      Giagtzoglou N, Alifragis P, Delidakis C

    European College of Neuropsychopharmacology (ECNP)
    12th Congress in London, UK (Sept. 21-25, 1999)

    • Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year placebo-controlled attrition study.

      Mohs R, Doody R, Morris J, Ieni J, Rogers S, Perdomo C, et al.

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1999, 19th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Copenhagen, Denmark (June 13-17, 1999)

    • The pattern of synaptophysin expression after middle cerebral artery occlusion and post-infarction MK-801 treatment.

      Kent TA, Bolanos SH, Fabian RH, Rea C

    • A new interpretation of bolus transit MRI yields quantitative cerebral blood flow.

      Williams JP, DeWitt DS, Quast MJ, Hillman GR, Kent TA

    European Neurological Society (ENS)
    9th Annual Meeting in Milan, Italy (June 5-9, 1999)

    • Optimal donepezil efficacy in Alzheimer's disease is dependent on continued administration.

      Doody RS, Geldmacher DS, Pratt RD, Perdomo CA

    International Society for Magnetic Resonance in Medicine (ISMRM)
    7th Annual Meeting in Philadelphia, Penn. (May 22-28, 1999)

    • Apparent diffusion coefficient images in subacute stroke detects DNA fragmentation.

      Kent TA, Gu Z, Quast MJ, Perez-Polo JR

    American Heart Association
    24th International Joint Conference on Stroke and Cerebral Circulation in Nashville, Tenn. (May 4-6, 1999)

    • APE/Ref-1 DNA repair enzyme following middle cerebral artery occlusion/reperfusion.

      Kent TA, Edwards M, Izumi T, Mitra S, Perez-Polo JR

    American Academy of Neurology (AAN)
    51st Annual Meeting in Toronto, Canada (April 17-24, 1999)

    • EEG utility for diagnosing herpes simplex encephalitis in the PCR era.

      Al-Shekhlee A, Zaidat O, Suarez JI

    • Does ApoE4 correlate with MRI changes in Alzheimer's disease?

      Azher S, Doody RS, Haykal H, Dunn JK, Liao T-Y

    • Clinical benefits of donepezil: Results from a long-term phase III extension trial.

      Doody RS, Pratt R, Perdomo C

    • Long term outcome following medical reversal of transtentoiral herniation in patients with supratentorial mass lesions.

      Geocadin RG, Qureshi AI, Suarez JI, Ulatowski JA

    • Prediction and timing of tracheostmy in patients with infratentorial lesions of the brain.

      Suarez JI, Qureshi AI, Parekh P, Bhardwaj A

    British Society for Developmental Biology (BSDB)
    BSCB/BSDB Joint Spring Meeting in Manchester, England (April 13-16, 1999)

    • A drosophila homologue of c. elegans PAR-1.
      [Platform Presentation]

      Shulman JM

    Genetics Society of America (GSA)
    40th Annual Drosophila Research Conference in Bellevue, Wash. (March 24-28, 1999)

    • A drosophila homologue of c. elegans PAR-1.
      [Platform Presentation]

      Shulman JM

    American Society of Neuroimaging (ASN)
    22nd Annual Meeting in Scottsdale, Ariz. (Feb. 24-27, 1999)

    • Cerebal blood flow velocity asymmetry following aneurysmal SAH.

      Razumovsky AY, Suarez JI, Qureshi AI, Parekh PD, Ulatowsku JA, Williams MA, et al.

    Mashad University of Medical Sciences
    (Dissertation) (1999)

    • Prospective study of electromyographic and electroneurographic changes in peripheral motor and sensory nerves in patients with organophosphate poisoning.

      Jalali N, Balali-Mood M

    Society for Neuroscience (SFN)
    28th Annual Meeting in Los Angeles, Calif. (Nov. 7-12, 1998)

    • Sensitivity of diffusion-weighted MRI to apoptotic cell death in middle cerebral artery ischemia-reperfusion.

      Gu Z, Wei J, Rea HC, Quast MJ, Kent TA, Perez-Polo JR

    European College of Neuropsychopharmacology (ECNP)
    11th Congress in Paris, France (Oct. 31 - Nov. 4, 1998)

    • Donepezil improves cognition and global function in Alzheimer's disease: Results from U.S. and multinational phase III clinical trials.

      Petit H, Doody RS, Pratt R

    American Society of Anesthesiologists (ASA)
    1998 Annual Meeting in Orlando, Fla. (Oct. 17-21, 1998)

    • Impaired autoregulation of cerebral flow by hemodilution.

      Rebel A, Ulatowski JA, Suarez JI, Bucci E, Waschke KF, Traystman RJ, et al.

    6th International Conference on Alzheimer's Disease and Related Disorders
    Amsterdam, The Netherlands (July 18-23, 1998)

    • Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease patients.

      Doody RS, Clark C, Farlow M, Foster N, Gonzales N, Liao J, et al.

    • The presence of APO E4 does not influence rate of decline in Alzheimer's disease.

      Kataki M, Doody RS, Liao J, Sims J

    European Society of Neurosonology and Cerebral Hemodynamics (ESNCH)
    3rd Meeting in Glasgow, Scotland (May 24-26, 1998)

    • Sensitivity and specificity of TCD in detection of symptomatic vasospasm after aneurysmal SAH.

      Suarez JI, Qureshi AI, Parekh PD, Ulatowski JA, Williams MA, Hanley DF, et al.

    American Academy of Neurology (AAN)
    50th Annual Meeting in Minneapolis, Minn. (April 25 - May 2, 1998)

    • Cerebrovascular risk factors and the risk of symptomatic cerebral vasospasm following subarachnoid hemorrhage.

      Geocadin RG, Qureshi AI, Suarez JI, Parekh PD, Tamargo RJ, Bhardwaj A, et al.

    Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy
    Geneva, Switzerland (April 15-18, 1998)

    • Current therapeutic standards in the treatment of Alzheimer's disease.

      Doody RS

    • Research outcome measures in Alzheimer's disease: Statistical significance, effect size and responder analysis - How do they translate to clinical relevance?

      Rogers S, Mohs R, Friedhoff L, Doody RS

    Genetics Society of America (GSA)
    39th Annual Drosophila Research Conference in Washington, DC (March 25-29, 1998)

    • Subcellular relocalization of dishevelled mediates polarity signaling.
      [Platform Presentation]

      Shulman JM

    American Epilepsy Society (AES)
    51st Annual Meeting in Boston, Mass. (Dec. 7-10, 1997)

    • Mutation of the voltage-dependent calcium channel beta subunit gene Cchb4 is associated with absence seizures and ataxia in the lethargic (lh) mouse.

      Burgess DL, Jones JM, Meisler MH, Zilinski CA, Noebels JL

    • A mutation in the sodium/hydrogen exchanger-1 gene causes ataxia and epilepsy in the slow-wave epilepsy mutant mouse.

      Cox GA, Lutz CM, Biemesderfer D, Bronson RT, Aronson PS, Noebels JL, et al.

    • Long-term seizure outcome in 35 patients with Lennox-Gastaut Syndrome.

      Goldsmith IL, Zupanc ML

    • Risk factors for neonatal seizures: A population-based study, Harris County, TX, 1992-1994.

      Saliba RM, Annegers JF, Waller DK, Mizrahi EM

    • Subtype-specific downregulation of glutamate transporter gene expression in three models of temporal lobe epilepsy.

      Sutherland ML, Delaney TA, Noebels JL

    Society for Neuroscience (SFN)
    27th Annual Meeting in New Orleans, La. (Oct. 25-30, 1997)

    • Theta-rhythmic neuronal activity in anterior thalamic nuclei of the rat.

      Kirk IJ, Albo Z, Vertes RP

    Society for Neuropediatrics
    23rd Annual Meeting in Munich, Germany (Oct. 17-19, 1997)

    • A fuzzy logic method to identify brain structures in MRI using expert anatomic knowledge.

      Chang C-W, Kent TA, Ying H, Yen J, Ketonen L, Hillman GR

    Society of Neurosurgical Anesthesia and Critical Care (SNACC)
    25th Annual Meeting in San Diego, Calif. (Oct. 17, 1997)

    • Use of hypertonic 3% saline infusion in treatment of cerebral edema: effect on intracrainal pressure and lateral displacement of the brain.

      Qureshi AI, Suarez JI, Bhardwaj A, Ulatowski JA, Hanley DF

    • Treatment of refractory intracranial hypertension with 23.4% saline.

      Suarez JI, Qureshi AI, Bhardwaj A, Ulatowski JA, Hanley DF

    American Neurological Association (ANA)
    122nd Annual Meeting in San Diego, Calif. (Sept. 28 - Oct. 1, 1997)

    • Multiple aneurysms are associated with cigarette smoking.

      Qureshi AI, Suarez JI, Parekh P, Bhardwaj A, Sung G

    • MRI findings in 16 patients with chronic progressive radiation myelopathy.

      Goldsmith IL, Cascino TL, Kimmel DW

    • Hypertonic saline as a treatment modality for cerebral edema and intracranial hypertension: clinical and radiographic correlation.

      Suarez JI, Bhardwaj A, Ulatowski JA, Hanley DF

    XVI World Congress of Neurology (WCN)
    Buenos Aires, Argentina (Sept. 14-19, 1997)

    • Use of hypertonic (3%) saline infusion in treatment of cerebral edema: effect on intracranial pressure and lateral displacement of the brain.

      Qureshi AI, Suarez JI, Bhardwaj A, Ulatowski JA, Hanley DF

    • Treatment of refractory intracranial hypertension with 23.4% saline.

      Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Ulatowski JA, Hanley DF

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1997, 18th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Baltimore, Md. (June 15-19, 1997)

    • Relationship between reduction in cerebral blood flow and superoxide anion following fluid percussion injury of the brain.

      Fabian RH, DeWitt DS, Kent TA

    • Quantitative cerebral blood flow changes using contrast enhanced MRI.

      Kent TA, Mottet I, Quast MJ, DeWitt DS, Hillman GR

    Aerospace Medical Association (AsMA)
    68th Annual Meeting in Chicago, Ill. (May 11-15, 1997)

    • Neuro-otologic evaluation of spatial disorientation and vestibular dysfunction in naval aviation personnel.

      Clark JB, Hopkins III EW

    • Case report II. Severe and prolonged drowsiness, fatigue, and mood changes in the aviator referred for air sickness.

      Lawson BD, Mead AM, Clark JB

    • Cardiovascular responses to a mixed-gas breathing paradigm for hypoxia induction.

      Sausen KP, Chimiak JM, Bower EA, Stiney ME, Clark JB

    American Academy of Neurology (AAN)
    49th Annual Meeting in Boston, Mass. (April 15-17, 1997)

    • Mechanisms of acute posterior cerebral artery territory infarction.

      Chang HM, Yamamoto Y, Georgiadis AL, Pessin MS, Caplan LR

    • Outcome measures in dementia trials-video CIBIC validity and reliability.

      Quinn JF, Benson DF, Clark C, Doody RS, Jagust W, Knopman D, et al.

    American Heart Association
    22nd International Joint Conference on Stroke and Cerebral Circulation in Anaheim, Calif. (Feb. 6-8, 1997)

    • Superoxide production by neutrophils in stroke.

      Fabian RH, Kent TA

    • Quantitating change in cerebral blood flow by MRI.

      Kent TA, Mottet I, Quast MJ, DeWitt DS, Hillman GR

    Asian Fuzzy Systems Society (AFSS)
    1996 Asian Fuzzy Systems Symposium in Kenting, Taiwan (Dec. 11-14, 1996)

    • Automatic generation of membership functions for brain MR images.

      Chang C-W, Hillman GR, Ying H, Kent TA, Yen J

    American College of Neuropsychopharmacology (ACNP)
    35th Annual Meeting in San Juan, Puerto Rico (Dec. 9-13, 1996)

    • Donepezil HCI (E2020) improves cognitive and global function in patients with mild and moderately severe Alzheimer's disease: Results of a 15-week phase III study.

      Rogers SL, Doody RS, Mohs RC, Friedhoff LT

    Society for Neuroscience (SFN)
    26th Annual Meeting in Washington, DC (Nov. 16-21, 1996)

    • Long lasting changes in cortical excitatory amino acid receptor levels and dopamine-induced behavior after neonatal excitotoxic lesions of the ventral hippocampus in rats.

      Albo Z, Flores G, Barbeau D, Quirion R, Srivastava LK

    • Production of extracellular superoxide anion during reperfusion following cerebral ischemia correlates with cerebral infarction.

      Fabian RH, Kent TA

    Society of Neurotrauma
    14th Annual Meeting in Washington, DC (Nov. 15-16, 1996)

    • Oxidative stress and ischemia.

      Kent TA, Taglialatela G, Rassin D, Quast M, Wei G, Rea C, et al.

    American Neurological Association (ANA)
    121st Annual Meeting in Miami, Fla. (Oct. 13-16, 1996)

    • Clinico-anatomic correlation of sensory findings in posterior cerebral artery territory infarction.
      [Previously Presented]

      Georgiadis AL, Yamamoto Y, Kwan ES, Pessin MS, Caplan LR

    • Urokinase for acute ischemic stroke.

      Suarez JI, Tarr R, Selman WR, Landis DMD

    Institute of Electrical and Electronics Engineers (IEEE)
    5th IEEE International Conference on Fuzzy Systems in New Orleans, La. (Sept. 8-11, 1996)

    • A fuzzy rule-based system for labeling the structures in 3D human brain magnetic resonance images.

      Chang C-W, Hillman GR, Ying H, Kent TA, Yen J

    Joint 3rd World Stroke Congress and 5th European Stroke Conference
    Munich, German (Sept. 1-4, 1996)

    • Clinico-anatomic correlation of sensory findings in posterior cerebral artery territory infarction.

      Georgiadis AL, Yamamoto Y, Kwan ES, Pessin MS, Caplan LR

    International Society for Developmental Neuroscience (ISDN)
    11th Biennial Meeting in Tampere, Finland (July 31 - Aug. 3, 1996)

    • Neurotrophins in acute stroke.

      Kent TA, Perez-Polo R, Hulsebosch CE

    Aerospace Medical Association (AsMA)
    67th Annual Meeting in Atlanta, Ga. (May 5-9, 1996)

    • Spatial orientation mobile field laboratory assessment of U.S. Navy divers exposed to underwater sound.

      Clark JB, Ferreira EA, McGrath BJ

    • Implementation of a marine aircraft wing sustained operations plan during combat (Operation Desert Storm).

      Clark JB, Schuyler CL

    • Assessment of eye movements during high intensity underwater (U/W) sound exposures in U.S. Navy divers.

      Ferreira EA, McGrath BJ, Clark JB

    • U.S. Navy experience with type II decompression sickness and the association with patent foramen ovale.

      Gallagher KL, Hopkins EW, Clark JB, Hawley TA

    International Behavioral Neuroscience Society (ISBN)
    5th Annual Meeting in Cancun, Mexico (May 2-5, 1996)

    • Prevalence of uncontrolled hypertension in a population of Alzheimer's patients.

      Kashani A, Doody RS, Wayner MJ, Phelix CF

    Undersea and Hyperbaric Medical Society (UHMS)
    1996 Annual Scientific Meeting in Anchorage, Alaska (April 30 - May 5, 1996)

    • Assessment of vestibular function of divers exposed to high intensity low frequency underwater sound.

      Clark JB, Russell KL, Knafelc ME, Steevens CC

    Genetics Society of America (GSA)
    37th Annual Drosophila Research Conference in San Diego, Calif. (April 27 - May 1, 1996)

    • Dishevelled is a multifunctional signal transducer.
      [Platform Presentation]

      Shulman JM

    American Academy of Neurology (AAN)
    48th Annual Meeting in San Francisco, Calif. (March 23-30, 1996)

    • Rate of dementia of the Alzheimer's type (DAT) in subjects with mild cognitive impairment.

      Grundman M, Petersen R, Morris J, Ferris S, Sano M, Farlow M, et al.

    • E-2020 Produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer's disease (AD): Results of a 30-week phase III trial.

      Rogers S, Doody RS, Mohs R, Friedhoff L

    • Pharmacologic evidence for autonomic psudomotor dysfunction in patients with Alzheimer's disease.

      Sabbagh N, Smith RG, Lynn P, Doody RS, Appel SH, Killian JH

    International Neuropsychological Society (INS)
    24th Annual Meeting in Chicago, Ill. (Feb. 14-17, 1996)

    • Reliability and validity of a new clinical global rating scale for Alzheimer's clinical trials.

      Olin J, Clark C, Doody RS, Schmitt F, Ferris S, Morris J, et al.

    Institute of Electrical and Electronics Engineers (IEEE)
    International Joint Conference of CFSA/IFIS/SOFT '95 in Taipei, Taiwan (Dec. 7-9, 1995)

    • Automatic labeling of human brain structures in 3D MRI using fuzzy logic.

      Chang C-W, Hillman GR, Ying H, Kent TA, Yen J

    Radiological Society of North America (RSNA)
    81st Annual Meeting in Chicago, Ill. (Nov. 26 - Dec. 1, 1995)

    • Cerebral angiography following traumatic brain injury (TBI) in a rat model.

      Esch 0, DeWitt D, Crow W, Walser E, Kent TA, vanSonnenberg E

    Gerontological Society of America (GSA)
    50th Annual Meeting in Los Angeles, Calif. (Nov. 15-19, 1995)

    • A new clinical global rating scale for Alzheimer's clinical trials.

      Olin J, Schneider L, Clark C, Doody RS, Ferris S, Morris J, et al.

    Society for Neuroscience (SFN)
    25th Annual Meeting in San Diego, Calif. (Nov. 11-16, 1995)

    • Cortical NMDA receptor levels are increased in adult rats following neonatal excitotoxic lesions of the ventral hippocampus.

      Albo Z, Flores G, Barbeau D, Quirion R, Srivastava LK

    • Disorders of the nervous system.

      Quast M, Kent TA, Taglialatela G, Huang N, Pizzo D, Hulsebosch C, et al.

    • Effects of ischemia on neurotrophin and GSH.

      Quast M, Kent TA, Taglialatela G, Huang N, Pizzo D, Hulsebosch C, et al.

    American Society of Anesthesiologists (ASA)
    1995 Annual Scientific Meeting in Atlanta, Ga. (Oct. 21-25, 1995)

    • Increased cerebral vascular resistance and impaired autoregulation after brain trauma MRI evidence.

      DeWitt DS, Kent TA, Quast MJ, Jenkins LW, Prough DS

    American Neuropsychiatric Association (ANPA)
    7th Annual Meeting in Pittsburgh, Penn. (Oct. 12-15, 1995)

    • Estrogen and psychomotor performance.

      Doody RS, Young R, Lynn P, Cooke N, Rosenfield JE

    Heinrich Fabri Institute
    2nd International Conference on Brain Energy Metabolism: Molecules to Man in Blaubeuren, Germany (Aug. 6-11, 1995)

    • Oxidative stress and cell death in the nervous system.

      Tong LQ, Taglialatela G, Pizzo D, Kent TA, Quast M, Werrbach-Perez K, et al.

    American Psychiatric Association (APA)
    148th Annual Meeting in Miami, Fla. (May 20-25, 1995)

    • Impulsivity: Syndrome or symptom.

      Barratt R, Tourian K, Kent TA

    Aerospace Medical Association (AsMA)
    66th Annual Meeting in Anaheim, Calif. (May 7-11, 1995)

    • Human factors in navy/marine fixed and rotary wing class-a mishaps involving 3rd generation night vision goggles (NVG) 1987-1993.

      Clark JB, Patterson FR

    • Atrial fibrillation associated with airsickness.

      Schindler ES, Clark JB

    American Academy of Neurology (AAN)
    47th Annual Meeting in Seattle, Wash. (May 6-13, 1995)

    • A calculated measure to predict rate of progression in Alzheimer's disease.

      Doody RS, Lynn P, Massman PJ

    Institute of Electrical and Electronics Engineers (IEEE)
    4th IEEE International Conference on Fuzzy Systems (FUZZ-IEEE/IFES'95) in Yokohama, Japan (March 20-24, 1995)

    • A two-stage human brain MRI segmentation scheme using fuzzy logic.

      Chang C-W, Hillman GR, Ying H, Kent TA, Yen J

    Society of Photo-Optical Instrumentation Engineers (SPIE)
    Medical Imaging 1995: Image Processing Conference in San Diego, Calif. (Feb. 27, 1995)

    • Automatic system for brain MRI analysis using a novel combination of fuzzy rule-based an automatic clustering techniques.

      Hillman GR, Chang C-W, Ying H, Kent TA, Yen J

    American Heart Association
    20th International Joint Conference on Stroke and Cerebral Circulation in Charleston, South Carolina (Feb. 9-11, 1995)

    • Toward quantitative cerebral blood flow by contrast-enhanced MRI: Analysis of the arterial input function and modulation during cerebral autoregulation.

      Lalonde DR, DeWitt DS, Jenkins LW, Huang N, Dong T, Quast MJ, et al.

    International Neuropsychological Society (INS)
    23rd Annual Meeting in Seattle, Wash. (Feb. 8-11, 1995)

    • Sex differences involving naming in Alzheimer's disease: Stronger relationships with left hemisphere functioning in men.

      Massman PJ, Doody RS

    Institute of Electrical and Electronics Engineers (IEEE)
    1st International Joint Conference of NAFIPS/IFIS/NASA in San Antonio, Texas (Dec. 18-21, 1994)

    • Segmentation of rat brain MR images using a hybrid fuzzy system.

      Chang C-W, Hillman GR, Ying H, Kent TA, Yen J

    Society for Neuroscience (SFN)
    24th Annual Meeting in Miami Beach, Fla. (Nov. 13-18, 1994)

    • Amphetamines permanently promote recovery following cortical infarction.

      Stroemer RP, Kent TA, Hulsebosch CE

    European College of Neuropsychopharmacology (ECNP)
    7th Congress in Jerusalem, Israel (Oct. 16-21, 1994)

    • Phenytoin normalizes ERPS among impulsive aggressive inmates.

      Barratt ES, Stanford MS, Kent TA, Felthous A

    International Union of Basic and Clinical Pharmacology (IUPHAR)
    3rd IUPHAR Satellite Meeting on Serotonin in Chicago, Ill. (July 30 - Aug. 3, 1994)

    • Serotonin affects the gene NFI in vascular smooth muscle.

      Kent TA

    American Academy of Neurology (AAN)
    46th Annual Meeting in Washington, DC (May 1-7, 1994)

    • Psychometric profiles of Alzheimer's disease (AD) with/without white matter changes compared to subcortical ischemic vascular dementia (IVD).

      Doody RS, Massman PJ, Nance ML

    • Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs.

      Massman PJ, Kreiter KT, Jankovic J, Doody RS

    International Neuropsychological Society (INS)
    22nd Annual Meeting in Cincinnati, Ohio (Feb. 2-5, 1994)

    • Neuropsychological differentiation of corticobasal degeneration from Alzheimer's disease.

      Massman PJ, Kreiter KT, Jankovic J, Doody RS

    Society for Neuroscience (SFN)
    23rd Annual Meeting in Washington, DC (Nov. 7-12, 1993)

    • Impulsive aggression and cortical dysfunction.

      Barratt ES, Stanford MS, Felthous A, Kent TA

    • Analysis of prefrontal tissue volumes following closed head injury in children and adolescents.

      Lilly MA, Berryhill P, Hillman GR, Levin HS, Kent TA, Brunder DB

    • Amphetamines promote anatomical plasticity and behavioral recovery following cortical infarction.

      Stroemer RP, Kent TA, Hulsebosch CE

    Society of Neurotrauma
    11th Annual Neurotrauma Symposium in Washington, DC (Nov. 6-7, 1993)

    • Neural plasticity after cerebral Infarction.

      Stroemer P, Hulsebosch CE, Kent TA

    American Neurological Association (ANA)
    118th Annual Meeting in Boston, Mass. (Oct. 18-20, 1993)

    • Dysfluency in the speech of AD patients.

      Doody RS, Massman P

    • Literacy and cognition in northern Thailand.

      Doody RS, Welsh K

    • The impact of extended deprenyl treatment in Parkinson's disease patients not requiring levodopa therapy.

      Shoulson I, Parkinson Study Group

    American Society of Human Genetics (ASHG)
    43rd Annual Meeting in New Orleans, La. (Oct. 5-9, 1993)

    • Simulation analysis of a large British pedigree segregating a newly characterized autosomal dominant language disorder: Familial developmental dysphasia.

      Dunn W, Doody RS, Gopnik M, Ashizawa T

    International Symposium on Cerebral Blood Vessel
    Mt. Zao, Japan (May 28-30, 1993)

    • Tumor suppressor gene expression in blood vessels.

      Ahlgren-Beckendorf T, Kent TA

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1993, 16th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Sendai, Japan (May 22-28, 1993)

    • Perfusion, deoxygenation and cytotoxicity in acute stroke.

      Huang N, Quast MJ, Hillman GR, Kent TA

    • Multiple serotonin receptor subtypes stimulates DNA synthesis in the basilar artery.

      Kent TA

    • Classification of brain compartments and lesions by a neural network applied to MR images.

      Kischell ER, Hillman GR, Kehtarnavaz N, Kent TA

    American Psychiatric Association (APA)
    146th Annual Meeting in San Francisco, Calif. (May 22-27, 1993)

    • Neuroimaging findings and clinical variables associated with psychosis in Alzheimer's disease.

      Kotrla K, Chacko R, Jhingran S, Doody RS

    International Neuropsychological Society (INS)
    21st Annual Meeting in Galveston , Texas (Feb. 24-27, 1993)

    • Correlates of asymmetric motor speed in Alzheimer's disease.

      Massman P, Doody RS

    American Heart Association
    18th International Joint Conference on Stroke and Cerebral Circulation in Miami Beach, Fla. (Feb. 11-13, 1993)

    • The relationship between cellular vulnerability and perfusion in acute stroke.

      Quast ME, Huang N, Hillman GR, Kent TA

    • Sprouting and synaptogenesis following cortical infarction.

      Stroemer P, Hulsebosch C, Kent TA

    National Academy of Neuropsychology (NAN)
    12th Annual Meeting in Pittsburgh, Penn. (Nov. 5-7, 1992)

    • Neuropsychological correlates of apraxia in Alzheimer's disease patients.

      Massman P, Doody RS

    Society for Neuroscience (SFN)
    22nd Annual Meeting in Anaheim, Calif. (Oct. 25-30, 1992)

    • Neuronal specification of direction and distance during reaching movements in the premotor and primary motor cortex of monkeys.

      Fu Q, Suarez JI, Ebner TJ

    • Synaptophysin levels are altered after cerebral ischemia.

      Stroemmer P, Hulsebosch C, Kent TA

    • Increases in GAP43 immunoreactivity after cortical infarction.

      Stroemmer RP, Kent TA, Hulsebosch CE

    Houston Society for Engineering in Medicine and Biology (HSEMB)
    10th Annual Meeting in Houston, Texas (March 19-20, 1992)

    • The evolution of acute stroke recorded by multimodal high field magnetic resonance imaging.

      Huang N, Quast MJ, Kent TA, Hillman GR

    American Anthropological Association (AAA)
    90th Annual Meeting in Chicago, Ill. (Nov. 20-24, 1991)

    Society of Photo-Optical Instrumentation Engineers (SPIE)
    International Symposium OE/FIBERS'91, Curves and Surfaces in Computer Vision and Graphics II in Boston, Mass. (Nov. 12, 1991)

    • Measurement of brain compartment volumes from MRI data using region growing and mixed volume methods.

      Hillman GR, Kent TA, Agris JM

    Society for Neuroscience (SFN)
    21st Annual Meeting in New Orleans, La. (Nov. 10-15, 1991)

    • Synaptophysin levels in cerebral ischemia.

      Stoemmer P, Kent TA, Hulsebosch C

    IEEE Engineering in Medicine and Biology Society (EMBS)
    13th Annual International Conference in Orlando, Fla. (Oct. 31 - Nov. 3, 1991)

    • A novel method for 3-D segmentation and volume estimation of brain compartments from MRI.

      Agris JM, deFigueiredo RJP, Hillman GR, Kent TA

    Society for Psychophysiological Research (SPR)
    31st Annual Meeting in Chicago, Ill. (Oct. 9-13, 1991)

    • Parietal late slow wave complex differences between impulsive aggressive prisoners and controls.

      Barratt ES, Stanford M, Kent TA

    American Neurological Association (ANA)
    116th Annual Meeting in Seattle, Wash. (Sept. 28 - Oct. 2, 1991)

    • Single photon emission computerized tomography (SPECT) in Alzheimer's disease and multiple-infarct dementia.

      Doody RS, Strittmatter WJ, Jhingran S

    • Establishing the limits of the mini-mental state: MMS "subtests" versus a full neuropsychological battery.

      Feher E, Mahurin R, Doody RS, Cooke N, Simms J, Pirozzolo F

    • Positive and negative psychiatric symptoms in Alzheimer's disease.

      Mahurin R, Feher E, Doody RS, Inbody S

    International Society for Magnetic Resonance in Medicine (ISMRM)
    10th Annual Meeting in San Francisco, Calif. (Aug. 10-16, 1991)

    • Functional bone marrow imaging by contrast-enhanced MRI.

      Kent TA, Quast ME, Klinke S, Mader J

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1991, 15th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Miami, Fla. (June 1-6, 1991)

    • Calcium channels and mitogenesis in cultured basilar artery smooth muscle.

      Kent TA, Jazayeri A, Simard JM

    • Rapid cerebral perfusion imaging by MRI in cerebral ischemia.

      Quast MJ, Kent TA, Anderson AA

    • L-type calcium current in basilar artery cells in transiently increased by isoproterenol, forskolin and cAMP.

      Simard JM, Kent TA, Sandleback B, Leppla D

    Aerospace Medical Association (AsMA)
    62nd Annual Meeting in Cincinnati, Ohio (May 5-9, 1991)

    • Patent foramen ovale and type II altitude decompression sickness.

      Clark JB, Hayes GB

    American Academy of Neurology (AAN)
    43rd Annual Meeting in Boston, Mass. (April 21-27, 1991)

    • The alien hand and related signs.

      Doody RS, Jankovic J

    American Association of Neurological Surgeons (AANS)
    59th Annual Meeting in New Orleans, La. (April 20-25, 1991)

    • cAMP is positively coupled to calcium channels in basilar artery smooth muscle cells.

      Simard JM, Kent TA, Sandleback B

    American Heart Association
    16th International Joint Conference on Stroke and Cerebral Circulation in San Francisco, Calif. (Feb. 21-23, 1991)

    • Contrast-enhanced MRI in experimental stroke.

      Quast MJ, Huang N, Kent TA

    American College of Neuropsychopharmacology (ACNP)
    29th Annual Meeting in San Juan, Puerto Rico (Dec. 10-14, 1990)

    • Serotonin binding to human white blood cells.

      Kent TA, Jazayeri A, Doren B

    American Anthropological Association (AAA)
    89th Annual Meeting in New Orleans, La. (Nov. 27 - Dec. 2, 1990)

    Society for Neuroscience (SFN)
    20th Annual Meeting in St. Louis, Mo. (Oct. 28 - Nov. 2, 1990)

    • Phenytoin improves brain functions among impulsive aggressive prisoners.

      Barratt E, Kent TA, Bryant S, Felthous A, Stanford M

    • ERP topography in episodically aggressive prisoners.

      Barratt ES, Kent TA, Sanford M, Bryant SG

    American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
    37th Annual Meeting in Chicago, Ill. (Sept. 7-8, 1990)

    • Recurrent posterior-type aphasia associated with a seizure focus.

      Doody RS, Hrachovy RA

    International Union of Basic and Clinical Pharmacology (IUPHAR)
    2nd IUPHAR Satellite Meeting on Serotonin in Basel, Switzerland (July 11-13, 1990)

    • Serotonin as a vascular smooth muscle cell (SMC) mitogen.

      Kent TA, Jazayeri AJ, Simard JM

    • Serotonin, protein kinase C and Ca2+ channels in basilar artery cells.

      Simard JM, Kent TA, Jazayeri AJ

    American Association of Neurological Surgeons (AANS)
    58th Annual Meeting in Nashville, Tenn. (April 28 - May 3, 1990)

    • Contractile responses of single isolated cells from the basilar artery.

      Leppla D, Simard JM, Kent TA

    • Isolation of arteriolar microvessels from cerebral cortex and culture of smooth cells.

      Seidel M, Simard JM, Kent TA

    • Vasospasm at the molecular level: What can calcium channels tell us?

      Simard JM, Kent TA

    American Academy of Neurology (AAN)
    42nd Annual Meeting in Miami, Fla. (April 2-4, 1990)

    • Progressive nonfluent aphasia.

      Feher E, Doody RS, Whitehead J, Priozzolo F

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1989, 14th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Bologna, Italy (May 28 - June 1, 1989)

    • Dextrorphan reduces infarct volume after middle cerebral occlusion in rats: An MR and histopathology study.

      Kent TA, Eisenberg H, Quast M, Anderson A, Hillman G, Campbell G

    • Dual effects of serotonin on calcium currents in basilar artery cells correlate with binding studies.

      Simard JM, Kent TA, Leppla D, Jazayeri A

    Society for Neuroscience (SFN)
    18th Annual Meeting in Toronto, Canada (Nov. 13-18, 1988)

    • Phase contrast MR imaging in cerebral ischemia at 4.7 T.

      Quast MJ, Ward GW, Trieff R, Kent TA

    International Society for Magnetic Resonance in Medicine (ISMRM)
    7th Annual Meeting in San Francisco, Calif. (Aug. 20-26, 1988)

    • Phase contrast imaging in cerebral ischemia.

      Quast MJ, Kent TA

    • Combined imaging and phase encoded 1 H/31 P spectroscopy in focal cerebral ischemia at 4.7 T.

      Quast MJ, Kent TA, Bradley R, Eisenberg HM, Litsey R, Kadekero M

    American College of Neuropsychopharmacology (ACNP)
    26th Annual Meeting in San Juan, Puerto Rico (Dec. 9-14, 1987)

    • Blood platelet uptake in episodic aggression.

      Kent TA, Brown C, Bryant SF, Felthous A, Barratt E, Rose RM

    Society for Neuroscience (SFN)
    17th Annual Meeting in New Orleans, La. (Nov. 16-21, 1987)

    • Effects of nicotine on blood platelet uptake of serotonin.

      Cinciripini PA, Kent TA

    • MRI and contrast agents in experimental cerebral ischemia.

      Kaplan BG, Kent TA, Quast ME

    International Society for Magnetic Resonance in Medicine (ISMRM)
    6th Annual Meeting in New York City, N.Y. (Aug. 17-21, 1987)

    • Cerebral blood flow mapping with magnetite microspheres and MRI.

      Kent TA, Quast ME, Kaplan BG, et al

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1987, 13th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Montreal, Quebec, Canada (June 20-25, 1987)

    • Quantitative blood:brain barrier and functional cerebral blood volume imaging by contrast-enhanced MR.

      Kent TA, Amparo EG, Najafi A, Gevedon RM

    • Effect of blood-brain barrier modification on murine herpes simplex virus myelitis.

      Kent TA, Woo W, Sadiq S, McKendall RR

    American Society of Neuroradiology (ASNR)
    25th Annual Meeting in New York City, N.Y. (May 10-15, 1987)

    • Quantitative cerebral blood volume imaging by MRI.

      Amparo EG, Kent TA, Najafi A, et al

    American Psychiatric Association (APA)
    140th Annual Meeting in Chicago, Ill. (May 9-14, 1987)

    • Blood platelet uptake of serotonin in chronically abstinent alcoholics.

      Campbell J, Kent TA, et al

    • Functional cerebral blood volume imaging by MRI.

      Kent TA, Amparo EG, Kaplan B, et al

    Society for Neuroscience (SFN)
    16th Annual Meeting in Washington, DC (Nov. 9-14, 1986)

    • Catecholamine influence on brain extracellular space.

      Kent TA, Oke A, Moghaddam B, Adams RN

    International Union of Physiological Sciences (IUPS)
    XXX Congress in Toronto, Canada (July 21-25, 1986)

    • Catecholamine influence on brain microenvironment.

      Kent TA, Oke AE, Adams RN

    American Psychiatric Association (APA)
    139th Annual Meeting in Washington, DC (May 10-16, 1986)

    • Brain water content in depression: An MRI study.

      Kent TA, Wassef A, Amparo G

    Society for Neuroscience (SFN)
    15th Annual Meeting in Dallas, Texas (Oct. 20-25, 1985)

    • Pharmacological characterization of adrenergic influence on brain extracellular space.

      Kent TA, Oke A, Adams RN

    • The blood:brain barrier (BBB) in murine herpes simplex virus (HSV) myelitis: Effect of high dose C02 on illness.

      McKendall RR, Woo W, Kent TA

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1985, 12th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Lund/Rönneby, Sweden (June 16-20, 1985)

    • Neural modulation of a brain extracellular space marker.

      Kent TA, Nagy G, Oke A, Adams RN

    • Cerebrovasculature responsiveness in the aged Fisher 344 rat.

      Kent TA, Yang RW, Croskell HW, Preskorn SH

    Undersea and Hyperbaric Medical Society (UHMS)
    1985 Annual Scientific Meeting in Long Beach, Calif. (June 11-14, 1985)

    • The effect of hyperbaric oxygen on the blood: Cerebrospinal fluid transfer of tobramycin.

      Kent TA, Sheftel TG, Mader JT

    Society for Neuroscience (SFN)
    14th Annual Meeting in Anaheim, Calif. (Oct. 10-15, 1984)

    • Cerebrovascular responsiveness in aging.

      Kent TA, Yang RY, Croskell H, Preskorn SH

    American Psychiatric Association (APA)
    137th Annual Meeting in Los Angeles, Calif. (May 5-11, 1984)

    • Platelet uptake of serotonin in chronic alcoholics.

      Kent TA

    • Symposium on norepinephrine: From lab to man.

      Kent TA, Hartman B, Preskorn SH, Swanson LD

    Society for Neuroscience (SFN)
    13th Annual Meeting in Boston, Mass. (Nov. 6-11, 1983)

    • Effects of inescapable shock on cerebral blood flow and the blood:brain barrier.

      Hughes CW, Kent TA, Croskell H, Campbell J, Preskorn SH

    • Effect of C02 on brain extracellular space: Neural regulation.

      Kent TA, Nagy G, Oke A, Preskorn S, Adams RN

    • Quantitative 2-DG study of the brainstem of the rat during nystagmus produced by lesion of the lateral semicircular ampulla.

      Kutyna FA, Patrickson JW, Bryant HJ, Kadekaro M, Clark JB

    • In vivo electrochemical detection of the effects of CO2 on biogenic amine release.

      Oke A, Kent T, Preskorn SH, Adams R

    • In vivo electrochemical detection of biogenic amines released by C02.

      Oke A, Kent TA, Adams RN

    • Effect of different classes of psychopharmaceuticals on cerebral blood flow and the blood:brain barrier.

      Swartzman J, Preskorn SH, Kent TA, Goldberg S

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1983, 11th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Paris, France (June 20-24, 1983)

    • Differential effects of central biogenic amines on cerebral blood flow and the blood:brain barrier.

      Kent TA, Preskorn SH, Solnick J, Irwin GH

    American Psychiatric Association (APA)
    136th Annual Meeting in New York City, N.Y. (April 30 - May 6, 1983)

    • The effect of psychotropic drugs on the cerebral circulation.

      Kent TA

    American Society for Clinical Pharmacology and Therapeutics (ASCPT)
    84th Annual Meeting in San Diego, Calif. (March 9-12, 1983)

    • EEG abnormalities due to high antidepressant levels.

      Preskorn SH, Othmer S, Lai CW, Othmer E, Kent TA

    Society for Neuroscience (SFN)
    12th Annual Meeting in Minneapolis, Minn. (Oct. 31 - Nov. 5, 1982)

    • Central nervous system glucose utilization rate in the nystagmic rat.

      Patrickson JW, Kutyna FA, Bryant HJ, Kadekaro M, Clark JB

    • Biogenic amine depletion alters cerebral microcirculation.

      Solnick J, Kent TA, Preskorn S, Irwin G

    American Psychiatric Association (APA)
    135th Annual Meeting in Toronto, Canada (May 15-21, 1982)

    • The cerebromicrocirculation in the tetrabenazine model of depression.

      Kent TA

    American College of Cardiology (ACC)
    31st Annual Scientific Session in Atlanta, Ga. (April 25-29, 1982)

    • Effects of stress management and dietary changes in treating ischemic heart disease.

      Ornish DM, Scherwitz LW, Doody RS, et al.

    Society for Neuroscience (SFN)
    11th Annual Meeting in Los Angeles, Calif. (Oct. 18-21, 1981)

    • Tetrabenazine model of depression: Changes in cerebral fluid dynamics and reversal with amitriptyline.

      Kent TA, Preskorn S, Glotzbach R, Irwin G

E-mail this page to a friend